Other infectious diseases

AB1_OTHER_INFECTIONS

infectious disease: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B99 Hospital discharge: ICD-9 — 136[8-9] Hospital discharge: ICD-8 — 1360[8-9] Cause of death: ICD-10 — B99 Cause of death: ICD-9 — 136[8-9] Cause of death: ICD-8 — 1360[8-9] 2 out of 7 registries used, show all original rules.	3249
4. Check minimum number of events None	3249
5. Include endpoints None	3249
6. Filter based on genotype QC (FinnGen only)	3138

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: B99-B99
Name in latin: Morbi infectiosi alii et non specificati

NAME	AB1_OTHER_INFECTIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B99
HD_ICD_9	136[8-9]
HD_ICD_8	1360[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B99
COD_ICD_9	136[8-9]
COD_ICD_8	1360[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infectious diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30118	14298	15550
Only index persons	25362	12247	13115
Unadjusted period prevalence (%)
Whole population	0.42	0.41	0.43
Only index persons	0.48	0.45	0.50
Median age at first event (years)
Whole population	65.84	66.85	64.81
Only index persons	64.46	65.47	63.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3138	1509	1629
Unadjusted period prevalence (%)	0.64	0.54	0.75
Median age at first event (years)	62.11	57.08	66.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3249: Matched controls
32490

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.3

307.7

1046

2271

B99

ICD-10 Finland

Other and unspecified infectious diseases

13513.5

307.7

3065

R50.9

ICD-10 Finland

Fever, unspecified

5.7

307.7

1168

2915

J01MA12

ATC

levofloxacin; systemic

3.4

205.9

1024

3909

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.0

191.6

1353

6277

A41.9

ICD-10 Finland

Sepsis, unspecified

5.8

160.1

312

586

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

150.1

697

2501

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

143.9

1854

11167

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

142.9

739

2818

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.1

131.7

204

303

J01MA14

ATC

moxifloxacin; systemic

3.5

128.2

504

1620

127

Kela drug reimbursment

Transplant complication

10.2

127.1

145

148

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

123.1

975

4608

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.8

121.5

196

304

TK800

NOMESCO Finland

Hemodialysis

7.3

119.1

180

260

L04AA06

ATC

mycophenolic acid; systemic

8.5

118.4

156

192

C03CA01

ATC

furosemide; systemic

2.3

117.0

1413

8041

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

11.4

111.2

117

106

13609

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus infectiosus sive parasitarius NUD

+∞

106.9

102

J01MA02

ATC

ciprofloxacin; systemic

2.2

101.7

1528

9362

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.4

97.7

129

159

ZX120

NOMESCO Finland

Intravenous

3.0

94.9

466

1697

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.5

93.8

244

582

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.3

89.8

245

606

A11CC03

ATC

alfacalcidol; systemic

5.6

88.6

173

323

JN4BD

NOMESCO Finland

Extensive body CT

2.8

88.0

494

1932

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.1

87.9

193

400

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.9

87.7

483

1869

B03XA02

ATC

darbepoetin alfa; parenteral

5.7

86.6

165

301

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.8

82.7

193

421

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.5

81.0

301

923

N18.0

ICD-10 Finland

End-stage renal disease

8.3

80.9

107

132

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.1

80.7

362

1246

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

79.2

794

4058

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

79.1

1220

7364

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

79.0

722

3548

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

79.0

485

1980

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

78.1

309

985

N02AA05

ATC

oxycodone; systemic

2.3

76.7

767

3910

A12AA04

ATC

calcium carbonate; oral

6.6

76.3

124

193

Z94.0

ICD-10 Finland

Kidney transplant status

9.1

76.3

106

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.9

76.0

H02AB06

ATC

prednisolone; systemic

2.0

75.7

1676

11425

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.6

75.2

146

271

A41.8

ICD-10 Finland

Other specified sepsis

5.7

73.7

139

251

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

72.5

702

3521

J01DB01

ATC

cefalexin; oral

2.4

72.3

2712

22140

L04AX01

ATC

azathioprine; systemic

4.0

70.7

209

547

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.0

70.0

108

159

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.6

69.0

169

383

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

69.0

164

363

L04AD01

ATC

ciclosporin; systemic

6.5

68.8

114

181

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.6

68.1

168

383

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

10.4

68.0

L04AA01

ATC

[U] ciclosporin

7.7

68.0

128

ZXD05

NOMESCO Finland

Urgent procedure

2.0

67.4

1127

6911

A46

ICD-10 Finland

Erysipelas

2.3

66.7

612

2991

M04AA01

ATC

allopurinol; systemic

2.3

65.7

607

2974

196

Kela drug reimbursment

Paricalcitol and cinacalcet

14.3

64.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

64.4

1064

6478

A02BC02

ATC

pantoprazole; systemic

1.9

62.8

2242

17409

Z2446

NOMESCO Finland

Social worker

3.0

62.4

299

1064

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

61.2

707

3777

N02AX02

ATC

tramadol; systemic, rectal

1.8

61.0

1478

10134

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.9

60.7

142

WW500

NOMESCO Finland

Blood transfusion

3.6

60.1

210

616

R53

ICD-10 Finland

Malaise and fatigue

2.0

60.1

892

5213

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

59.1

229

718

Z3231

NOMESCO Finland

Registered nurse

1.9

58.9

990

6027

V03AE02

ATC

sevelamer; oral

14.5

58.8

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

58.8

215

650

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

58.3

725

3973

J01FF01

ATC

clindamycin; systemic

1.9

58.1

946

5694

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

57.9

404

1742

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

57.5

1206

7869

L04AD02

ATC

tacrolimus; systemic

8.2

56.8

B34.9

ICD-10 Finland

Viral infection, unspecified

4.5

56.7

140

319

A07AA09

ATC

vancomycin; oral

6.3

56.7

159

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

55.7

609

3173

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

55.6

375

1590

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

55.2

1651

11931

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

54.9

644

3445

A03

ICPC

Fever

2.1

52.7

564

2910

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

51.7

645

3522

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

51.4

598

3182

A10AB05

ATC

insulin aspart; parenteral

2.6

51.4

337

1408

1369X

ICD-9 Finland

Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases

+∞

51.2

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

15.2

51.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

50.8

758

4401

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.0

50.8

V03AE01

ATC

polystyrene sulfonate; oral

5.6

50.3

175

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.1

49.1

221

757

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.1

48.0

215

734

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

47.6

453

2225

B01AB05

ATC

enoxaparin; parenteral

1.8

47.5

1053

6897

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.9

47.3

241

884

L03AA02

ATC

filgrastim; parenteral

3.9

46.9

141

373

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

46.8

1206

8236

UJF32

NOMESCO Finland

Coloscopy

1.8

46.8

896

5613

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

45.4

232

852

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

44.7

426

2090

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.0

44.6

134

H05BX01

ATC

cinacalcet; oral

8.7

43.5

B01AA03

ATC

warfarin; systemic

1.8

43.5

795

4895

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.1

43.4

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

43.4

850

5343

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

42.9

180

591

Z50.1

ICD-10 Finland

Other physical therapy

2.8

42.7

224

834

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.6

42.6

107

ZXE00

NOMESCO Finland

One hour or less

1.7

42.5

1258

8860

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

42.4

412

2036

N02BE01

ATC

paracetamol; systemic, rectal

2.1

42.2

2821

24760

Z3226

NOMESCO Finland

Physiotherapist

1.9

41.7

640

3723

H02AB02

ATC

dexamethasone; systemic

2.2

41.5

398

1955

N03AX16

ATC

[U] pregabalin

1.8

41.4

772

4772

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

41.3

205

741

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

40.7

263

1088

A10AC01

ATC

insulin (human); parenteral

2.3

40.2

334

1547

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

39.8

1068

7299

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

39.8

256

1056

C07AB07

ATC

bisoprolol; oral

1.6

39.7

1648

12580

JN4AD

NOMESCO Finland

Body CT examination

2.2

39.6

371

1805

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

39.2

315

1437

137

Kela drug reimbursment

Uraemia requiring dialysis

6.6

39.2

R4110

NOMESCO Finland

Physiotherapy

1.7

39.0

900

5898

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

38.9

1241

8857

A10AE04

ATC

insulin glargine; parenteral

2.2

38.9

379

1871

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

38.7

316

1452

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

38.1

274

1190

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

38.0

623

3691

A04AA01

ATC

ondansetron; systemic, rectal

2.4

37.4

283

1257

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.3

37.4

NHQ40

NOMESCO Finland

Amputation of toe

4.5

37.2

210

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

37.2

417

2171

H02AB07

ATC

prednisone; oral

2.0

37.1

490

2702

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

37.1

528

2987

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.2

36.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

36.1

131

393

R11

ICD-10 Finland

Nausea and vomiting

2.2

36.1

319

1513

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.4

35.2

129

L28

ICPC

Limited function/disability (L)

1.8

34.8

640

3916

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

34.3

477

2673

A04AA02

ATC

granisetron; systemic, transdermal

2.5

34.2

228

956

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

33.7

595

3591

A07AA02

ATC

nystatin; oral

2.5

33.7

227

956

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

33.6

376

1952

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

4.2

33.4

224

B03XA01

ATC

erythropoietin; parenteral

5.8

33.3

107

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

6.2

33.2

WW200

NOMESCO Finland

Immunization

3.5

33.1

115

336

A06AD11

ATC

lactulose; oral

1.8

32.8

570

3421

13608

ICD-8 Finland

Other and unspecified infective and parasitic diseases

+∞

32.3

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

32.3

240

1056

A02BC01

ATC

omeprazole; systemic

1.6

32.3

891

6071

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

31.9

271

1263

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

31.8

417

2286

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.4

31.4

183

Z2221

NOMESCO Finland

Medical doctor

1.6

31.2

858

5831

N05CF01

ATC

zopiclone; oral

1.6

30.8

1057

7576

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

12.0

30.8

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

8.1

30.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

30.1

147

526

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.6

30.0

100

284

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

30.0

198

M10.9

ICD-10 Finland

Gout, unspecified

2.2

29.8

271

1298

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

29.8

195

H02AB09

ATC

hydrocortisone; systemic

3.6

29.6

282

ZX108

NOMESCO Finland

Inhalation

6.7

29.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

29.2

366

1973

V03AE03

ATC

lanthanum carbonate; oral

10.1

29.2

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

6.3

29.2

A05AA02

ATC

ursodeoxycholic acid; oral

4.4

29.0

165

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

28.4

160

617

P01AB01

ATC

metronidazole; oral, rectal

1.5

28.4

1151

8527

H02AB04

ATC

methylprednisolone; systemic

1.8

28.4

460

2695

AA1AD

NOMESCO Finland

CT of head and brain

1.6

28.2

900

6316

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

28.1

355

1919

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.7

28.1

S97

ICPC

Chronic ulcer skin

2.2

27.6

235

1096

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

27.4

353

1920

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

27.4

204

898

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.8

27.2

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

27.1

873

6130

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

27.1

812

5607

SPAT1255

SPAT

Intravenous administration of medicine

2.2

27.0

250

1205

N19

ICD-10 Finland

Unspecified kidney failure

2.6

26.9

159

629

TGC00

NOMESCO Finland

Bronchial lavation

3.2

26.8

105

331

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

26.8

148

566

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

26.7

127

448

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

26.7

187

801

A10AE05

ATC

insulin detemir; parenteral

2.3

26.7

205

915

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

26.4

261

1290

A28

ICPC

Limited function/disability NOS

1.7

26.4

611

3952

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

26.4

150

582

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

26.3

372

2086

Z49.2

ICD-10 Finland

Other dialysis

5.9

26.2

I50.0

ICD-10 Finland

Congestive heart failure

2.0

26.1

314

1667

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

26.1

268

1344

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.7

25.7

231

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.7

25.7

N06AX11

ATC

mirtazapine; oral

1.5

25.5

1003

7345

B05DB

ATC

Hypertonic solutions

6.1

25.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

25.4

458

2763

3AC01, ,

NOMESCO Finland

4.9

25.3

113

UKC02

NOMESCO Finland

Cystoscopy

1.7

25.2

566

3627

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

25.2

313

J02AC01

ATC

fluconazole; systemic

1.5

25.0

1043

7726

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.6

24.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

24.8

587

3814

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

24.8

313

1690

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.2

24.7

101

327

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

24.6

884

6337

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

24.6

269

1381

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

24.1

1037

7719

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.8

24.1

114

ZY010

NOMESCO Finland

Hospital outpatient

2.4

24.0

162

682

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

24.0

188

846

L03AA13

ATC

pegfilgrastim; parenteral

2.6

24.0

142

562

J01CA04

ATC

amoxicillin; systemic

1.5

23.9

2436

21473

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

23.9

171

740

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

23.8

171

741

SPAT1254

SPAT

Administration of medicine

1.7

23.7

497

3124

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

23.6

289

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

23.6

264

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.6

1305

10201

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

23.6

138

543

N05AH04

ATC

quetiapine; oral

1.7

23.5

516

3284

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

23.4

106

364

C03DA01

ATC

spironolactone; oral

1.8

23.1

412

2475

ZX112

NOMESCO Finland

Subcutaneous

3.3

23.1

268

Z51.5

ICD-10 Finland

Palliative care

2.0

23.0

282

1505

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

23.0

178

R06.0

ICD-10 Finland

Dyspnoea

1.5

22.9

842

6050

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

22.9

676

4625

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

22.8

789

5594

B05DA

ATC

Isotonic solutions

5.4

22.8

PAW37

NOMESCO Finland

Biopsy of temporal artery

5.6

22.7

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.1

22.7

307

WX002

NOMESCO Finland

Sedation and analgesia

1.6

22.7

597

3975

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

22.4

240

1221

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

22.4

225

1119

N05BA04

ATC

oxazepam; oral

1.5

22.3

785

5583

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.3

22.3

A10AD05

ATC

insulin aspart; parenteral

3.1

22.2

295

H26.3

ICD-10 Finland

Drug-induced cataract

6.5

22.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

22.1

101

349

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

21.7

203

981

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.2

21.7

K65.0

ICD-10 Finland

Acute peritonitis

4.1

21.5

142

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.8

21.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

21.4

165

738

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

21.3

389

2349

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

21.2

261

1394

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.6

21.2

110

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

21.1

266

1433

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

21.1

192

919

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

21.1

123

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.1

21.1

294

P01BA02

ATC

hydroxychloroquine; oral

2.0

20.9

241

1260

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.4

20.8

J01XX08

ATC

linezolid; systemic

5.5

20.7

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.7

20.7

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

20.7

303

1714

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

20.7

232

1201

A02BC05

ATC

esomeprazole; systemic

1.4

20.6

1165

9079

TK810

NOMESCO Finland

Hemofiltration

6.4

20.5

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.4

20.5

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

20.4

242

1276

N05BA01

ATC

diazepam; systemic, rectal

1.7

20.4

403

2486

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

20.4

162

733

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

20.4

228

1178

WX892

NOMESCO Finland

Monitored bed care

1.9

20.4

254

1363

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

20.3

705

4987

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.5

20.2

WVA20

NOMESCO Finland

Medicine administration

2.9

20.2

339

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

20.2

176

828

ZZA00

NOMESCO Finland

Split skin graft

2.6

20.1

113

436

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

20.0

177

837

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

20.0

249

1335

205

Kela drug reimbursment

Chronic hypertension

1.5

20.0

912

6816

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.6

20.0

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.5

20.0

131

545

J01EA01

ATC

trimethoprim; systemic

1.5

19.9

773

5596

N06AB04

ATC

citalopram; systemic

1.6

19.8

609

4193

L04AA13

ATC

[U] leflunomide

3.1

19.7

274

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

19.7

134

567

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

19.6

158

719

J01AA02

ATC

doxycycline; systemic

1.5

19.6

2322

20562

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.5

19.6

105

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

19.5

338

2010

RD210, ,

NOMESCO Finland

3.5

19.4

200

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

19.4

614

4249

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

19.4

100

369

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.3

19.4

144

633

L04AX03

ATC

methotrexate; systemic

1.9

19.3

277

1555

C08CA01

ATC

amlodipine; oral

1.4

19.3

1179

9289

Z99.2

ICD-10 Finland

Dependence on renal dialysis

31.5

19.2

SPAT1263

SPAT

Sampling

1.4

19.2

1212

9605

E000001, ,

ATC

1.6

19.1

574

3926

QDA10

NOMESCO Finland

Incision of skin of lower limb

5.2

19.1

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.2

19.1

248

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

19.0

129

545

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.7

19.0

165

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.9

19.0

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

18.9

125

522

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.6

18.9

J01FA06

ATC

roxithromycin; oral

1.4

18.9

1151

9057

I50.1

ICD-10 Finland

Left ventricular failure

2.1

18.8

194

973

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.0

18.8

287

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

18.7

187

927

A12BA01

ATC

potassium chloride; oral

2.1

18.7

183

901

RS220, ,

NOMESCO Finland

3.8

18.7

153

RS221, ,

NOMESCO Finland

3.7

18.6

158

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

18.5

126

533

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

18.5

1247

9977

K92.1

ICD-10 Finland

Melaena

2.0

18.5

194

980

R31

ICD-10 Finland

Unspecified haematuria

1.7

18.4

354

2167

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

18.4

131

566

N30.0

ICD-10 Finland

Acute cystitis

1.6

18.3

466

3063

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

18.3

509

3419

WX730

NOMESCO Finland

Conventional respirator

3.5

18.3

179

M46.4

ICD-10 Finland

Discitis, unspecified

6.9

18.2

NFQ20

NOMESCO Finland

Amputation of femur

4.4

18.2

103

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.6

18.2

N17.8

ICD-10 Finland

Other acute renal failure

3.7

18.1

152

K83.0

ICD-10 Finland

Cholangitis

3.3

18.0

200

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

18.0

279

1605

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

17.9

138

617

E0000UV, ,

ATC

1.4

17.8

1172

9322

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

7.3

17.8

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.9

17.8

131

J01CF02

ATC

cloxacillin; systemic

2.8

17.7

308

C08CA02

ATC

felodipine; oral

1.7

17.6

320

1926

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.4

17.6

118

496

L01BA01

ATC

methotrexate; systemic

2.4

17.5

118

497

ZXA00

NOMESCO Finland

Right side

1.5

17.5

801

5964

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.8

17.5

137

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.9

17.4

Z51.88

ICD-10 Finland

Other specified medical care

3.0

17.4

262

E86

ICD-10 Finland

Volume depletion

2.6

17.3

103

409

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

17.3

162

784

R81

ICPC

Pneumonia

2.4

17.3

121

519

SPAT1262

SPAT

Handing over of treatment supplies

1.5

17.2

535

3680

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.2

17.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

17.2

154

733

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.8

17.2

139

E87.5

ICD-10 Finland

Hyperkalaemia

2.9

17.0

276

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

17.0

200

1053

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.1

16.9

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.9

16.9

266

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

16.9

766

5688

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

16.8

141

653

R42

ICD-10 Finland

Dizziness and giddiness

1.5

16.8

679

4933

A04

ICPC

Weakness/tiredness general

1.6

16.8

445

2952

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.2

16.7

106

R55

ICD-10 Finland

Syncope and collapse

1.7

16.7

353

2213

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.1

16.6

C07AB02

ATC

metoprolol; systemic

1.5

16.5

667

4842

J05AB11

ATC

valaciclovir; oral

1.6

16.5

394

2548

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

16.5

217

1186

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

16.4

116

500

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.4

16.4

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.2

16.3

208

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

16.3

1987

17368

A49

ICD-10 Finland

Bacterial infection of unspecified site

6.5

16.2

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.4

16.1

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

16.1

113

485

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

16.1

123

548

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

16.1

382

AN1

Coronary angiography

1.6

16.1

372

2386

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

16.1

184

959

N05CF02

ATC

zolpidem; oral

1.6

16.1

470

3187

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

21.0

16.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

15.9

309

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

15.8

770

5783

A12AA12

ATC

[U] calcium acetate

14.5

15.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

15.8

138

TAB00

NOMESCO Finland

Lumbar puncture

2.2

15.7

130

599

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

15.7

190

1009

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

6.9

15.7

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

13.0

15.6

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

15.6

158

B01AB10

ATC

tinzaparin; parenteral

1.7

15.6

284

1710

J96.0

ICD-10 Finland

Acute respiratory failure

3.3

15.6

183

A29

ICPC

General symptom/complaint other

1.6

15.6

377

2445

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

15.6

152

748

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

15.5

269

1598

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

15.4

197

1065

H3603, E103,

ICD-10 Finland

4.4

15.4

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

15.4

230

1307

R51.80

ICD-10 Finland

Headache

1.6

15.3

408

2705

Z94.1

ICD-10 Finland

Heart transplant status

12.4

15.3

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.4

15.3

165

N06AX16

ATC

venlafaxine; oral

1.6

15.2

358

2305

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

15.2

175

914

WZC30

NOMESCO Finland

Teaching

1.6

15.2

442

2992

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.8

15.1

119

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.3

15.1

114

506

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

15.0

117

526

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.0

15.0

219

WX213

NOMESCO Finland

Lower leg blockade

4.4

15.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

14.9

285

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

6.5

14.9

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

14.9

762

5769

R60.0

ICD-10 Finland

Localized oedema

1.6

14.8

367

2394

J01MA06

ATC

norfloxacin; oral

1.6

14.7

382

2517

N05CD07

ATC

temazepam; oral

1.6

14.7

385

2542

SPAT1229

SPAT

Assessment of need for aid

1.8

14.7

249

1469

NGQ20

NOMESCO Finland

Amputation of lower leg

4.6

14.7

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

14.7

700

5230

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

14.7

535

3797

A10AB01

ATC

insulin (human); parenteral

2.3

14.7

113

506

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

14.6

176

934

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.8

14.6

272

SPAT1301

SPAT

No procedures

1.4

14.5

901

7043

R33

ICD-10 Finland

Retention of urine

1.7

14.5

283

1736

C02AC05

ATC

moxonidine; oral

2.0

14.4

150

756

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

14.4

114

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

14.3

263

5BA08, ,

NOMESCO Finland

5.0

14.3

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

14.3

150

759

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

14.2

339

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.2

14.2

178

ZXA05

NOMESCO Finland

Left side

1.4

14.2

726

5490

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

14.1

209

1184

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.4

14.1

149

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

14.1

241

1426

N03AX12

ATC

[U] gabapentin; oral

1.5

14.1

455

3148

M10.3

ICD-10 Finland

Gout due to impairment of renal function

5.4

14.0

M05BX04

ATC

denosumab; parenteral

1.9

14.0

176

948

C01DA14

ATC

isosorbide mononitrate; oral

1.5

14.0

553

3986

R52.0

ICD-10 Finland

Acute pain

2.3

13.9

101

441

A01AB09

ATC

miconazole; local oral

1.7

13.9

252

1516

M05BA04

ATC

alendronic acid; oral

1.7

13.8

260

1579

C01AA05

ATC

digoxin; systemic

1.6

13.8

302

1910

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

13.7

338

2198

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.5

13.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

13.7

419

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

13.7

147

212

Kela drug reimbursment

Gout

2.6

13.7

322

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

13.7

151

778

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

13.6

119

561

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

13.6

361

2391

WX882

NOMESCO Finland

High dependency care

2.4

13.5

384

R03BB04

ATC

tiotropium bromide; inhalant

1.6

13.5

328

2126

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

13.5

289

L01AA01

ATC

cyclophosphamide; systemic

5.2

13.4

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

13.4

185

1027

R02

ICPC

Shortness of breath/dyspnoea

1.6

13.4

370

2473

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.7

13.3

279

R07.3

ICD-10 Finland

Other chest pain

1.6

13.3

295

1871

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

13.2

101

451

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

13.2

130

642

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.7

13.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

13.2

472

3332

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

13.2

188

1054

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.5

13.2

131

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

13.1

559

4081

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

13.1

122

WX610

NOMESCO Finland

Patient controlled analgesia

4.5

13.1

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

13.0

226

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.7

13.0

260

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.2

13.0

K81.0

ICD-10 Finland

Acute cholecystitis

2.6

12.9

301

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

6.1

12.9

N06AA09

ATC

amitriptyline; systemic

1.7

12.9

273

1710

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.1

12.9

168

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.3

12.9

RS222, ,

NOMESCO Finland

3.4

12.9

138

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

12.8

120

582

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

12.8

124

609

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

12.8

127

630

A07EA06

ATC

budesonide; oral, local oral

2.3

12.8

445

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.1

12.8

124

610

A10BA02

ATC

metformin; oral

1.4

12.7

841

6616

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.7

12.7

110

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

12.7

247

1515

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

12.7

456

3222

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

12.6

353

2363

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

12.6

162

878

N03AX09

ATC

lamotrigine; oral

2.1

12.6

123

606

J01CA08

ATC

pivmecillinam; oral

1.3

12.6

1024

8314

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.3

12.6

145

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

12.5

171

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

12.5

187

K56.7

ICD-10 Finland

Ileus, unspecified

2.8

12.5

231

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

12.5

148

782

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.5

12.4

325

E000006, ,

ATC

1.8

12.4

186

1058

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

12.4

151

804

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.3

12.4

N06AB10

ATC

escitalopram; oral

1.5

12.4

501

3620

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

12.4

206

1210

D07AA02

ATC

hydrocortisone; topical

1.5

12.4

369

2507

C07AG02

ATC

carvedilol; oral

1.8

12.2

188

1078

WX402

NOMESCO Finland

General anaesthesia

1.4

12.2

532

3895

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.3

12.2

409

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.3

12.2

133

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

12.1

103

481

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

12.1

161

883

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

4.1

12.1

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

12.0

224

1357

H04AA01

ATC

glucagon; nasal, parenteral

2.7

12.0

242

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

12.0

425

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

12.0

208

1236

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.1

12.0

160

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

11.9

262

1656

TPX15

NOMESCO Finland

Removal of vascular injection port

5.7

11.9

K92.0

ICD-10 Finland

Haematemesis

2.3

11.9

375

C10AC01

ATC

colestyramine; oral

2.4

11.9

338

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.8

11.9

N05AH03

ATC

olanzapine; systemic

1.8

11.9

167

932

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

11.9

159

874

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.5

11.9

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

11.8

402

SPAT1138

SPAT

Guidance concerning bowel function

2.9

11.8

188

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.8

368

2523

C83.1

ICD-10 Finland

Mantle cell lymphoma

5.9

11.8

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

11.8

670

5137

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.7

235

1451

L03AA14

ATC

lipegfilgrastim; parenteral

2.8

11.7

205

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.1

11.7

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

11.7

298

B01AB04

ATC

dalteparin; parenteral

1.9

11.7

153

835

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.1

11.7

157

J04AB02

ATC

rifampicin; systemic

3.1

11.7

157

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

11.7

842

6701

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

11.7

234

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

11.7

161

894

A10BH05

ATC

linagliptin; oral

1.8

11.7

164

916

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

11.6

184

R10.0

ICD-10 Finland

Acute abdomen

2.2

11.6

437

R52.2

ICD-10 Finland

Other chronic pain

2.1

11.6

107

517

A10AB04

ATC

insulin lispro; parenteral

2.2

11.6

438

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.5

11.6

108

A01

ICPC

Pain general/multiple sites

1.6

11.5

253

1599

K50.8

ICD-10 Finland

Other Crohn disease

3.2

11.5

143

Z94.4

ICD-10 Finland

Liver transplant status

8.6

11.5

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

10.1

11.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

11.5

197

1167

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.0

11.5

E66.8

ICD-10 Finland

Other obesity

1.9

11.4

135

713

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.9

11.4

181

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.5

11.4

114

R06AE07

ATC

cetirizine; oral

1.3

11.4

1140

9502

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

15.1

11.3

C08CA05

ATC

nifedipine; systemic

1.7

11.3

194

1150

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

11.2

130

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.5

11.1

293

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.2

11.1

136

K85

ICD-10 Finland

Acute pancreatitis

2.7

11.1

206

K83.1

ICD-10 Finland

Obstruction of bile duct

2.9

11.1

173

N05AX08

ATC

risperidone; systemic

1.6

11.1

258

1656

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.1

11.0

152

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

11.0

447

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

10.9

258

1660

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

10.9

163

927

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.9

511

3789

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.7

10.8

C90.0

ICD-10 Finland

Multiple myeloma

3.0

10.8

154

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

10.7

323

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

10.7

121

629

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.4

10.7

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

10.7

156

881

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.1

10.7

139

N03AF02

ATC

oxcarbazepine; oral

2.1

10.7

459

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.6

10.7

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

10.7

293

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.1

10.7

104

513

QDG10

NOMESCO Finland

Excision and repair of bedsore of lower limb

21.5

10.7

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.3

10.7

119

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.7

10.7

199

J05AB01

ATC

aciclovir; systemic

1.4

10.6

571

4329

I20.00

ICD-10 Finland

Unstable angina

2.0

10.6

105

521

N05AD01

ATC

haloperidol; systemic

2.1

10.6

101

494

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.8

10.6

194

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.6

563

4263

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.6

1068

8889

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.6

988

8138

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.6

1041

8636

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

10.5

208

1281

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.7

10.5

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

4.4

10.5

D11

ICPC

Diarrhoea

1.5

10.5

290

1936

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

4.8

10.5

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.8

10.5

R4190

NOMESCO Finland

Nutritional therapy

2.1

10.4

470

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.4

10.4

106

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.2

10.3

A10BB12

ATC

glimepiride; oral

1.6

10.3

230

1460

R50.8

ICD-10 Finland

Other specified fever

4.3

10.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

10.3

355

2483

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.5

10.3

102

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

10.3

102

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.3

151

856

H05BX02

ATC

paricalcitol; systemic

18.8

10.3

JAH01

NOMESCO Finland

Laparoscopy

2.0

10.2

108

549

T89

ICPC

Diabetes insulin dependent

2.0

10.2

108

549

R52.9

ICD-10 Finland

Pain, unspecified

1.6

10.2

251

1631

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.0

10.2

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

10.2

288

1931

L17

ICPC

Foot/toe symptom/complaint

1.3

10.2

747

5941

D07AC01

ATC

betamethasone; topical

1.3

10.2

968

7983

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.5

10.2

239

I20.09

ICD-10 Finland

Unstable angina

1.7

10.2

184

1107

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

10.1

199

1223

RJ410, ,

NOMESCO Finland

5.3

10.1

SPAT1260

SPAT

Consultation of another employee

1.4

10.1

466

3442

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.7

10.1

188

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

10.1

199

1226

W19

ICD-10 Finland

Unspecified fall

1.5

10.0

277

1849

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

10.0

129

N05AA02

ATC

levomepromazine; systemic

1.9

10.0

116

609

C09AA05

ATC

ramipril; oral

1.3

10.0

743

5918

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

10.0

241

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.5

10.0

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.0

10.0

145

K56.0

ICD-10 Finland

Paralytic ileus

3.3

10.0

114

XQ902

NOMESCO Finland

Other photography

4.1

10.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.7

9.9

201

X57

ICD-10 Finland

Unspecified privation

2.4

9.9

297

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

9.9

480

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.8

9.8

168

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

9.8

255

R50.1

ICD-10 Finland

Persistent fever

12.2

9.8

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

9.8

468

3474

SPAT1172

SPAT

Guidance concerning hydration

2.2

9.8

349

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.8

318

2196

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.6

9.8

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.8

9.8

163

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.4

9.8

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.9

9.8

S06.0

ICD-10 Finland

Concussion

1.5

9.8

291

1974

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.5

9.8

226

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.4

9.8

262

3025

Kela drug reimbursment

Calcium carbonate

4.7

9.8

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

9.8

210

1322

SPAT1342

SPAT

Referral to specialised care

2.8

9.7

169

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

9.7

221

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.8

9.7

132

731

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

9.7

457

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

13.4

9.7

S70.0

ICD-10 Finland

Contusion of hip

1.9

9.6

122

660

SPAT1336

SPAT

Request for examination

1.9

9.6

113

596

J01CF05

ATC

flucloxacillin; systemic

1.7

9.6

165

978

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

9.6

116

618

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

9.6

698

5539

HAC20

NOMESCO Finland

Total mastectomy

2.0

9.6

486

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

9.6

153

889

WW200, ,

SPAT

0.7

9.6

315

4437

E000003, ,

ATC

1.9

9.6

116

619

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

9.5

419

J01DC02

ATC

cefuroxime; systemic

1.8

9.5

133

742

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

9.5

106

549

K86.3

ICD-10 Finland

Pseudocyst of pancreas

4.6

9.5

WNF00

NOMESCO Finland

Infection source and contact determination

4.6

9.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

9.5

1775

15863

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.1

9.5

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.2

9.5

341

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.3

9.5

322

B37.08

ICD-10 Finland

Other candidal stomatitis

3.8

9.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

9.5

1091

9203

J01DA01

ATC

[U] cefalexin

1.3

9.4

1762

15740

M54.5

ICD-10 Finland

Low back pain

1.3

9.4

918

7579

PE1AT

NOMESCO Finland

Femoral artery PTA

2.8

9.4

161

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

9.4

343

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

4.2

9.4

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

9.4

463

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.3

270

1820

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

9.3

318

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

9.3

262

M35.1

ICD-10 Finland

Other overlap syndromes

4.5

9.3

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.5

9.3

C09CA06

ATC

candesartan; oral

1.3

9.3

605

4721

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

9.5

9.3

130

Kela drug reimbursment

Malignant tumour

1.5

9.2

252

1677

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

3.8

9.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

9.2

100

514

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

9.2

234

1534

S29

ICPC

Skin symptom/complaint other

1.4

9.2

487

3680

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.9

9.2

107

564

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.3

9.2

100

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.3

9.1

284

J43.9

ICD-10 Finland

Emphysema, unspecified

2.5

9.0

211

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.4

9.0

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.2

9.0

106

C09AA02

ATC

enalapril; systemic

1.3

9.0

582

4534

WF004

NOMESCO Finland

Palliative radiotherapy

2.3

9.0

291

K08.3

ICD-10 Finland

Retained dental root

1.6

9.0

201

1277

G04CA02

ATC

tamsulosin; oral

1.3

9.0

743

5998

WX872

NOMESCO Finland

Intensive care

1.8

9.0

143

831

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.6

8.9

183

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.2

8.9

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.2

8.9

E83.50

ICD-10 Finland

Hypercalcemia

2.9

8.9

144

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

8.9

290

2005

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

8.9

102

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.9

8.9

139

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.8

8.8

150

M79.6

ICD-10 Finland

Pain in limb

1.3

8.8

1080

9159

K02.9

ICD-10 Finland

Dental caries, unspecified

2.6

8.8

190

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

8.8

123

687

C02CA01

ATC

prazosin; oral

2.3

8.8

269

R4180

NOMESCO Finland

Podiatric therapy

2.9

8.8

145

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

8.6

8.8

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.0

8.8

JAH00

NOMESCO Finland

Laparotomy

2.1

8.8

406

Angiography of the heart and coronary arteries

1.6

8.8

207

1333

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.3

8.8

301

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.0

8.8

129

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

8.8

152

905

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

8.7

105

559

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

8.7

311

2188

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

8.7

168

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.3

8.7

289

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

14.1

8.7

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.9

8.7

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.5

8.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.5

8.6

204

N03AX14

ATC

levetiracetam; systemic

2.1

8.6

362

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.4

8.6

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.4

8.6

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

8.6

114

627

AB1

AVR mechanical

4.8

8.6

D64.8

ICD-10 Finland

Other specified anaemias

2.4

8.6

241

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

8.6

285

R05

ICPC

Cough

1.3

8.6

600

4729

B37.7

ICD-10 Finland

Candidal sepsis

10.0

8.5

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

8.5

273

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

8.5

143

844

A07EC02

ATC

mesalazine; oral, rectal

1.8

8.5

135

784

M10.0

ICD-10 Finland

Idiopathic gout

1.9

8.5

107

579

M01CB01

ATC

sodium aurothiomalate; parenteral

2.8

8.5

148

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.2

8.5

299

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

4.2

8.4

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.7

8.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

7.3

8.4

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

8.4

243

B01AC04

ATC

clopidogrel; oral

1.4

8.4

481

3675

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

8.4

211

1379

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

8.4

496

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.3

8.4

256

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.2

8.4

333

J01FA09

ATC

clarithromycin; systemic

1.3

8.4

760

6203

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

8.4

106

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.7

8.3

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

8.3

196

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

8.3

214

TNG10

NOMESCO Finland

Puncture of knee

3.0

8.3

117

105

Kela drug reimbursment

Adrenal cortical hypofunction

10.8

8.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

8.3

210

1376

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

8.3

283

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

8.3

375

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

8.2

724

5883

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

8.2

134

784

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

8.2

281

1962

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.4

8.2

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.4

8.2

240

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

8.2

388

2876

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

6.5

8.2

A02BA02

ATC

ranitidine; systemic

1.3

8.2

537

4191

N05AX12

ATC

aripiprazole; systemic

2.0

8.2

452

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

8.1

185

1182

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

8.1

169

N06AX21

ATC

duloxetine; oral

1.5

8.1

279

1951

Catheterization and pressure measurement of the left side of the heart

2.3

8.1

273

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

8.1

273

PB1AE

NOMESCO Finland

Ultrasound examination of arteries of upper extremity

33.4

8.1

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

17.2

8.1

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

17.2

8.1

U71

ICPC

Cystitis/urinary infection other

1.7

8.1

156

957

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

8.1

201

1312

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.8

8.1

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

8.0

332

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

8.0

352

ZXA10

NOMESCO Finland

Bilateral

1.3

8.0

495

3825

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

8.0

259

1787

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.9

8.0

N06AB06

ATC

sertraline; oral

1.5

8.0

264

1829

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

10.0

8.0

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.0

266

1846

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

22.1

8.0

R13

ICD-10 Finland

Dysphagia

1.6

8.0

188

1210

Z75.5

ICD-10 Finland

Holiday relief care

2.8

8.0

136

M86.6

ICD-10 Finland

Other chronic osteomyelitis

6.3

8.0

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.2

8.0

281

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.5

8.0

200

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

8.0

207

1364

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.3

8.0

237

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

8.0

174

1101

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

8.0

104

570

J01FA01

ATC

erythromycin; systemic

1.4

7.9

319

2296

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

7.9

106

585

A02BC03

ATC

lansoprazole; oral

1.3

7.9

778

6408

J01XX05

ATC

methenamine; oral

2.9

7.9

126

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

7.9

375

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

13.0

7.9

C10AA01

ATC

simvastatin; oral

1.2

7.9

1224

10636

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

7.8

7.9

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

7.9

362

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.1

7.9

342

R4120

NOMESCO Finland

Occupational therapy

1.6

7.9

171

1081

B02.9

ICD-10 Finland

Zoster without complication

1.6

7.9

171

1081

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.0

7.8

403

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.8

955

8073

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.2

7.8

290

E87.6

ICD-10 Finland

Hypokalaemia

1.9

7.8

516

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.7

7.8

128

751

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.5

7.8

TK820

NOMESCO Finland

Peritoneal dialysis

4.1

7.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

7.8

119

684

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

10.8

7.8

J94.8

ICD-10 Finland

Other specified pleural conditions

2.4

7.8

227

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.8

128

752

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

7.8

517

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

4.2

7.7

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.2

7.7

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

15.0

7.7

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

3.1

7.7

101

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

7.7

247

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.5

7.7

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.3

7.7

RJ421, ,

NOMESCO Finland

4.3

7.7

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

7.7

352

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

7.7

250

1729

SPAT1211

SPAT

Application of soft bandage

1.5

7.7

231

1572

I50

ICD-10 Finland

Heart failure

1.9

7.7

100

548

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.7

434

3310

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.2

7.7

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

7.6

254

HA1AA

NOMESCO Finland

X-ray mammography

1.6

7.6

164

1035

-44

ICPC

Preventive immunization/medic

1.5

7.6

217

1461

A10AA01, ,

ATC

2.1

7.6

347

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

11.9

7.6

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

11.9

7.6

A97

ICPC

No disease

1.3

7.6

453

3484

UJD02

NOMESCO Finland

Gastroscopy

1.7

7.6

130

773

Z02.4

ICD-10 Finland

Examination for driving licence

0.8

7.6

485

6147

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

7.6

223

1511

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

7.5

161

1013

XF404

NOMESCO Finland

Ambulatory ECG

1.5

7.5

237

1627

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.8

7.5

124

J01DA09

ATC

[U] cefadroxil

1.3

7.5

681

5549

A04AD12

ATC

aprepitant; systemic

2.4

7.5

206

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

7.5

480

Z72.2

ICD-10 Finland

Drug use

4.2

7.5

J01MA01

ATC

ofloxacin; systemic

1.5

7.5

231

1581

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.5

630

5086

-2, ,

ICPC

3.7

7.5

N03AX18

ATC

lacosamide; systemic

3.9

7.4

G72.8

ICD-10 Finland

Other specified myopathies

2.3

7.4

232

G40.10

ICD-10 Finland

Simple partial seizures

3.5

7.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

7.4

171

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.3

7.4

226

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.3

7.4

226

A48.8

ICD-10 Finland

Other specified bacterial diseases

6.5

7.4

B07.9

ICD-10 Finland

Verruca simplex

1.9

7.4

447

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.1

7.4

297

C02EA02, ,

ATC

1.7

7.4

137

832

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.0

7.4

109

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

7.7

7.4

N02BF02

ATC

pregabalin; oral

1.7

7.4

139

848

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

7.4

351

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

7.3

137

N86

ICPC

Multiple sclerosis

4.0

7.3

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

2.9

7.3

115

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.0

7.3

386

RJ411, ,

NOMESCO Finland

3.6

7.3

A27

ICPC

Fear of other disease NOS

1.7

7.3

128

766

L01BB05

ATC

fludarabine; systemic

10.9

7.3

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

7.3

121

713

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

7.3

471

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

7.3

R03AC02

ATC

salbutamol; inhalant

1.2

7.3

1464

13040

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

7.2

146

906

C83.00

ICD-10 Finland

Lymphocytic lymphoma

6.2

7.2

H3600, E103,

ICD-10 Finland

3.0

7.2

105

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

7.2

137

837

Z00.8

ICD-10 Finland

Other general examinations

1.5

7.2

187

1232

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.8

7.2

127

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.4

7.2

210

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.2

162

1033

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

7.2

221

1511

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

7.2

156

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.7

7.2

K75.0

ICD-10 Finland

Abscess of liver

7.3

7.2

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

4.5

7.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1.9

7.2

445

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.9

7.2

J01FA10

ATC

azithromycin; systemic

1.2

7.1

1432

12739

187

Kela drug reimbursment

MPA

30.1

7.1

115

Kela drug reimbursment

Breast cancer

1.6

7.1

179

1171

T90

ICPC

Diabetes non-insulin dependent

1.3

7.1

632

5133

J01XE01

ATC

nitrofurantoin; oral

2.2

7.1

243

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

6.6

7.1

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.3

7.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.4

7.1

187

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.1

732

6057

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

7.1

163

R06.4

ICD-10 Finland

Hyperventilation

2.5

7.1

169

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

12.0

7.1

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.0

7.1

101

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.3

7.1

212

A41.4

ICD-10 Finland

Sepsis due to anaerobes

6.0

7.1

K65.9

ICD-10 Finland

Peritonitis, unspecified

6.0

7.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

7.0

1127

9793

N05AF03

ATC

chlorprothixene; systemic

2.1

7.0

303

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.0

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.0

R4130

NOMESCO Finland

Speech therapy

2.0

7.0

365

XX9XW, ,

NOMESCO Finland

3.5

7.0

D01

ICPC

Abdominal pain/cramps general

1.4

7.0

273

1956

M54.8

ICD-10 Finland

Other dorsalgia

1.8

7.0

105

602

A10AA02, ,

ATC

1.8

7.0

558

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

7.0

141

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.4

7.0

201

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.3

7.0

R18

ICD-10 Finland

Ascites

2.2

6.9

252

A10BB01

ATC

glibenclamide; oral

1.6

6.9

142

885

6BA02, ,

NOMESCO Finland

6.3

6.9

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

6.9

285

U70

ICPC

Pyelonephritis/pyelitis

2.5

6.9

171

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

6.9

106

611

L01BC06

ATC

capecitabine; oral

1.8

6.9

552

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

6.9

139

863

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.0

6.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.8

244

1718

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

6.8

103

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

6.8

225

1560

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

8.3

6.8

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.3

6.8

203

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

6.8

222

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

6.7

6.8

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.8

6.8

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.8

6.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.8

447

3484

N03AB02

ATC

phenytoin; systemic

2.6

6.8

137

A21.9

ICD-10 Finland

Tularaemia, unspecified

9.3

6.8

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

9.3

6.8

F03

ICD-10 Finland

Unspecified dementia

1.6

6.8

140

875

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.2

6.8

229

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

6.8

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.3

6.7

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.9

6.7

398

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

6.7

107

624

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

6.7

186

1245

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

2.6

6.7

144

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

6.7

L04AX04

ATC

lenalidomide; oral

3.4

6.7

D69.0

ICD-10 Finland

Allergic purpura

3.4

6.7

H65.0

ICD-10 Finland

Acute serous otitis media

2.4

6.7

180

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.1

6.7

296

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.5

6.7

156

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

6.7

137

855

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

22.6

6.7

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.6

226

1577

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

6.6

205

1403

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

6.6

386

N03AE01

ATC

clonazepam; systemic

1.6

6.6

139

872

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.6

890

7581

J20

ICD-10 Finland

Acute bronchitis

1.5

6.6

238

1679

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.0

6.6

331

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

5.5

6.6

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

5.5

6.6

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.5

6.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

6.6

572

4628

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

6.6

401

U14

ICPC

Kidney symptom/complaint

2.3

6.6

200

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.1

6.6

M05BA07

ATC

risedronic acid; oral

1.9

6.6

444

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.9

6.6

100

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

6.6

194

1316

C50.99

ICD-10 Finland

Breast, unspecified

2.0

6.6

332

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.6

209

1440

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

3.3

6.5

153

Kela drug reimbursment

Lenalidomid

3.3

6.5

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

8.7

6.5

Z94.2

ICD-10 Finland

Lung transplant status

8.7

6.5

A08

ICPC

Swelling

1.6

6.5

135

844

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

6.5

117

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.8

6.5

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

6.5

104

607

ZX110

NOMESCO Finland

Intracutaneous

6.8

6.5

S76

ICPC

Skin infection other

1.6

6.5

138

869

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.7

6.5

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

5.3

6.5

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.1

6.4

260

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

6.4

215

1495

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.0

6.4

307

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.6

6.4

141

M03BX01

ATC

baclofen; systemic

2.2

6.4

234

N04BC05

ATC

pramipexole; oral

1.5

6.4

191

1297

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.7

6.4

118

192

Kela drug reimbursment

Fulvestrant

3.9

6.4

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.5

6.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

3.5

6.4

E87.2

ICD-10 Finland

Acidosis

3.5

6.4

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

6.4

159

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.9

6.4

426

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.9

6.4

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

2.8

6.4

107

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.2

6.4

228

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.0

6.4

335

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

6.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.4

244

1742

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

3.7

6.4

WX199

NOMESCO Finland

Other local analgesia

1.8

6.3

493

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.5

6.3

154

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.3

428

J02AC03

ATC

voriconazole; systemic

6.5

6.3

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.5

6.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.3

298

2206

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.3

472

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

6.3

337

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.2

6.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.6

6.3

7151

FHL

Kidney transplantation

11.0

6.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.2

6.3

5AB14, ,

NOMESCO Finland

9.3

6.3

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

9.3

6.3

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.6

6.3

137

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.3

6.3

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

6.3

114

L04AA10

ATC

[U] sirolimus

18.0

6.3

AK1

HTX (heart transplant)

+∞

6.3

L12

ICPC

Hand/finger symptom/complaint

1.3

6.2

375

2884

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

6.2

357

2726

R05

ICD-10 Finland

Cough

1.3

6.2

515

4141

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

6.2

374

P03

ICPC

Feeling depressed

1.5

6.2

193

1324

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.9

6.2

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.4

6.2

162

D09

ICPC

Nausea

1.7

6.2

101

594

J01DA08

ATC

[U] cefaclor

1.4

6.2

233

1659

UJK02

NOMESCO Finland

ERCP

1.9

6.2

396

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

5.0

6.2

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

6.2

527

WX900

NOMESCO Finland

Resuscitation

4.0

6.2

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

6.2

232

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

6.1

112

679

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

6.1

120

741

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

6.1

193

1328

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

6.1

286

H3600, E113,

ICD-10 Finland

2.4

6.1

163

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.8

6.1

477

ZY000

NOMESCO Finland

Hospital inpatient

2.5

6.1

139

JKA20

NOMESCO Finland

Cholecystectomy

1.8

6.1

441

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.8

6.1

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.8

6.1

PD1CD

NOMESCO Finland

Very extensive CT of abdominal aorta and branches

4.1

6.1

R03BA05

ATC

fluticasone; inhalant

1.3

6.1

447

3538

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.3

6.1

176

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

6.1

471

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

8.6

6.0

120

Kela drug reimbursment

Hypogammaglobulinaemia

8.6

6.0

Z01.7

ICD-10 Finland

Laboratory examination

1.3

6.0

344

2624

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.9

6.0

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

2.9

6.0

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

6.0

225

1599

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.6

6.0

A86

ICD-10 Finland

Unspecified viral encephalitis

3.6

6.0

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

6.7

6.0

D05AX52

ATC

calcipotriol, combinations; topical

1.6

6.0

123

768

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.1

6.0

261

A10AD01

ATC

insulin (human); parenteral

2.0

6.0

288

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1631

7511

3.35

248.43

8.4

4.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1060

4481

3.03

174.89

2.9

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

579

1901

3.49

143.41

2.2

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

265

486

5.85

139.11

7.6

5.4

1248.52

736.84

iu/ml

0.34

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

780

3110

2.98

138.96

2.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

779

3109

2.98

138.49

2.4

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

400

1129

3.90

123.30

2.6

1.9

2.30

2.39

ug/l

0.03

366

982

(3002032) Base excess in Venous blood by calculation

652

2522

2.98

121.15

7.7

3.6

1.65

1.89

mmol/l

1.10

558

2089

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

286

639

4.81

119.76

2.4

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

217

381

6.03

118.94

3.6

3.0

246.47

2154.96

u/ml

1.19

(3012544) pH of Venous blood

657

2599

2.92

116.85

7.4

3.6

7.38

7.39

0.30

(3021447) Carbon dioxide [Partial pressure] in Venous blood

643

2529

2.92

115.46

7.6

3.6

5.74

5.84

kpa

1.67

631

2452

(3002582) Erythrocytes [#/volume] in Urine

1402

8028

2.31

113.56

5.3

3.3

57.31

78.58

e6/l

0.65

1194

6250

(3022096) Basophils/100 leukocytes in Blood

1794

11502

2.25

109.06

10.6

5.9

0.60

0.66

4.19

1714

10708

(3019069) Monocytes/100 leukocytes in Blood

1837

11923

2.24

107.92

11.1

6.2

8.79

8.71

0.45

1759

11135

(3006504) Eosinophils/100 leukocytes in Blood

1830

11870

2.24

107.53

10.7

5.8

2.68

2.83

1.96

1748

11062

(3030467) Casts [#/volume] in Urine by Automated count

1286

7291

2.26

104.55

5.2

3.2

0.39

0.45

e6/l

0.47

1089

5629

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

223

454

5.20

103.92

2.6

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

262

611

4.58

103.78

2.5

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

703

3051

2.66

103.48

6.1

4.0

248.27

247.24

u/l

0.05

679

2872

(3002030) Lymphocytes/100 leukocytes in Blood

1853

12224

2.20

102.46

10.9

6.0

24.79

27.21

15.13

1776

11449

(3003458) Phosphate [Moles/volume] in Serum or Plasma

765

3483

2.56

101.90

13.5

5.6

1.10

1.04

mmol/l

6.11

731

3222

(40760892) CBC W Ordered Manual Differential panel - Blood

1811

11858

2.19

101.81

11.4

6.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

302

805

4.03

100.25

1.6

1.2

—

(3006315) Basophils [#/volume] in Blood

1889

12626

2.19

100.10

10.1

5.6

0.04

e9/l

2.44

1708

10888

(3001604) Monocytes [#/volume] in Blood

1885

12591

2.18

100.03

10.1

5.6

0.62

0.60

e9/l

3.46

1698

10864

(3018095) Leukocytes [#/volume] in Urine

1509

9279

2.17

98.60

5.9

3.8

90.61

110.47

e6/l

0.28

1224

6675

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

194

370

5.51

97.17

1.8

1.6

—

(3026782) Osmolality of Urine

1021

5419

2.29

95.61

4.9

2.9

523.99

545.85

mosm/kgh2o

2.57

934

4658

(3019198) Lymphocytes [#/volume] in Blood

1910

12966

2.15

95.33

10.3

5.7

1.83

1.91

e9/l

0.37

1746

11443

(3020779) Urea [Moles/volume] in Serum or Plasma

589

2434

2.73

94.84

16.1

6.9

11.72

10.40

mmol/l

3.79

570

2304

(3013115) Eosinophils [#/volume] in Blood

1916

13061

2.14

94.08

10.6

5.8

0.19

e9/l

1.21

1734

11407

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1946

13353

2.14

93.80

11.5

6.0

11.51

12.02

umol/l

0.58

1882

12641

(3018010) Neutrophils/100 leukocytes in Blood

1805

12046

2.12

93.52

10.4

5.8

59.95

57.71

11.22

1731

11270

(3013650) Neutrophils [#/volume] in Blood by Automated count

2071

14650

2.14

90.87

17.0

8.5

4.48

4.20

e9/l

5.63

1893

12751

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

760

3633

2.43

89.85

4.9

2.5

21.31

22.48

1.26

680

3095

(3042936) Bacteria identified in Isolate by Culture

764

3669

2.42

89.34

2.8

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

164

291

5.88

88.65

1.9

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

521

2096

2.77

87.91

6.3

3.1

5.00

4.52

kpa

3.69

512

2026

(3004789) Transferrin [Mass/volume] in Serum or Plasma

789

3870

2.37

87.77

4.8

2.5

2.15

2.30

g/l

11.60

750

3564

(3000850) Epithelial cells [#/volume] in Urine

1033

5681

2.20

87.27

4.4

2.6

5.20

5.28

e6/l

0.08

969

5108

(3022217) INR in Platelet poor plasma by Coagulation assay

1821

12492

2.04

83.97

24.7

17.1

1.32

1.33

inr

0.18

619

3624

(3012095) Magnesium [Moles/volume] in Serum or Plasma

824

4190

2.30

83.79

5.8

3.2

0.79

0.82

mmol/l

6.62

781

3922

(3022948) Iron [Moles/volume] in Serum or Plasma

823

4192

2.29

83.29

4.8

2.5

11.14

12.74

umol/l

7.04

780

3888

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

200

460

4.57

80.31

1.9

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

427

1625

2.87

79.59

1.7

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

199

465

4.49

78.31

1.9

1.4

—

14.85

—

(36304419) Bacteria [Presence] in Urine

1186

7105

2.05

78.30

5.1

3.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

184

410

4.70

76.80

1.9

1.4

114.42

119.64

u/ml

0.16

(3005719) IgG [Mass/volume] in Serum or Plasma

454

1823

2.73

76.25

3.8

2.7

10.17

10.67

g/l

1.47

425

1655

(3000991) Gas panel - Venous blood

520

2248

2.56

75.19

11.8

8.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1649

11209

1.96

74.78

9.1

4.8

33.60

35.17

g/l

20.68

1559

10393

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

220

585

3.96

72.85

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

220

585

3.96

72.85

1.7

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1828

12945

1.94

72.53

14.8

6.7

1.21

mmol/l

0.86

1568

10944

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1276

8038

1.97

71.50

4.7

3.1

32.56

36.50

u/l

0.95

1217

7634

(3026008) Bacteria identified in Urine by Culture

1290

8158

1.96

71.45

4.6

3.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

308

1047

3.15

69.82

1.7

1.4

13.06

20.50

u/ml

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

820

4443

2.13

69.44

3.8

2.8

1.30

1.19

e6/l

0.23

513

2568

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

785

4187

2.15

69.21

3.9

3.0

2.28

2.29

e6/l

0.01

477

2324

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1261

7999

1.94

68.48

3.8

2.5

53.30

68.94

u/l

0.91

1204

7364

(3028026) IgM [Mass/volume] in Serum or Plasma

375

1439

2.82

68.37

2.0

1.9

1.18

1.44

g/l

1.80

337

1310

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

180

434

4.33

67.95

2.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

180

434

4.33

67.95

2.7

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2050

15270

1.93

67.74

9.7

4.8

6.97

6.80

mmol/l

2.64

1972

14310

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

181

453

4.17

65.02

1.5

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

348

1332

2.81

63.59

7.1

3.2

24.98

25.14

mmol/l

0.39

343

1291

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

172

422

4.25

63.43

1.5

1.3

308.95

257.09

u/ml

1.14

122

256

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

336

1269

2.84

62.94

8.1

3.9

23.71

23.99

mmol/l

0.91

331

1239

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

165

399

4.30

62.01

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

176

451

4.07

61.22

4.7

3.4

1.55

1.60

0.06

158

392

(3027945) Reticulocytes/100 erythrocytes in Blood

623

3189

2.18

60.07

3.7

2.5

1.84

1.78

0.80

584

2804

(3014111) Lactate [Moles/volume] in Serum or Plasma

506

2377

2.34

60.05

9.3

6.9

1.35

1.39

mmol/l

0.44

498

2317

(3004119) Hemoglobin [Mass/volume] in Venous blood

391

1635

2.58

59.84

6.7

3.1

123.28

128.15

g/l

4.01

385

1590

(3048929) Epstein Barr virus Ab [Presence] in Serum

219

679

3.39

57.53

1.5

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

341

4.44

57.35

1.6

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

742

4122

2.04

57.33

2.8

2.2

30.60

29.99

1.79

724

3992

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

435

3.99

56.76

1.7

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

596

3065

2.16

56.48

2.5

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

438

1988

2.39

55.99

7.3

3.8

139.05

92.57

ng/l

4.99

379

1702

(3010375) cycloSPORINE [Mass/volume] in Blood

103

7.73

55.67

27.8

27.1

100.00

119.88

ug/l

1.65

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

111

211

5.41

55.63

2.0

1.5

—

(3018418) pH of Serum or Plasma

1170

7631

1.83

55.35

9.3

3.9

7.40

0.21

255

1457

(3026250) Tacrolimus [Mass/volume] in Blood

7.89

54.48

42.6

35.2

7.34

7.03

ug/l

0.56

(40758558) Short blood count panel - Blood

1017

6404

1.86

53.51

12.6

6.3

—

(3023520) Reticulocytes [#/volume] in Blood

488

2363

2.25

53.50

4.3

2.5

69.05

69.22

e9/l

0.03

372

1811

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

319

1284

2.65

52.51

1.9

1.7

1.78

1.50

g/l

4.14

281

1098

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

366

1591

2.47

51.26

9.7

7.9

24.42

24.74

mmol/l

0.81

360

1581

(3017181) Myelocytes/100 leukocytes in Blood

447

2142

2.26

50.05

5.8

4.0

0.90

0.87

0.08

242

770

(3021589) Normoblasts [#/volume] in Blood

1534

11061

1.73

49.90

19.1

9.6

0.00

e9/l

0.93

1297

9032

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

480

2375

2.20

49.66

3.6

2.4

38.26

58.76

u/l

0.49

416

2026

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

233

826

2.96

48.72

1.7

1.5

424.44

240.00

titre

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

708

4068

1.95

48.71

2.3

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

547

2871

2.09

48.52

4.5

2.8

9.61

8.69

umol/l

0.31

481

2498

(3020630) Protein [Mass/volume] in Serum or Plasma

457

2242

2.21

48.21

3.3

2.5

64.38

66.39

g/l

5.95

423

2043

(3024891) Influenza virus A+B Ag [Presence] in Specimen

205

683

3.14

47.75

1.3

1.2

—

(1616796) Gas panel - Central venous blood

188

600

3.26

47.03

5.4

3.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

132

333

4.09

46.84

1.7

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1200

8202

1.73

46.34

4.0

2.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2137

17076

1.73

46.21

7.1

4.6

50.30

1806.61

e6/l

3.13

285

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

841

5187

1.84

46.12

5.4

3.8

243.56

612.90

ng/l

1.28

687

4187

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

142

384

3.82

45.75

1.7

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

509

2660

2.08

45.45

2.4

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1051

6953

1.76

45.35

3.0

2.2

3.26

3.00

mg/l

2.51

926

5898

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

195

654

3.11

44.88

2.0

1.5

0.24

g/l

0.03

182

620

(3015736) pH of Urine

1398

10023

1.69

44.88

5.4

3.4

5.92

5.85

0.31

641

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

296

1240

2.53

44.67

7.8

3.9

48.55

47.84

0.18

296

1225

(3002179) Metamyelocytes/100 leukocytes in Blood

400

1939

2.21

43.21

5.6

3.9

0.59

0.70

205

657

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2365

19606

1.76

43.09

16.0

7.3

89.92

79.35

u/l

9.90

2287

18448

(3037467) Urinalysis macro (dipstick) panel - Urine

2177

17653

1.71

42.83

7.3

4.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

683

3.01

42.79

2.1

1.5

1.18

g/l

0.03

185

646

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1572

11718

1.66

42.79

12.8

6.0

1.20

1.21

mmol/l

2.77

1495

10622

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

114

276

4.24

42.73

3.1

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

202

711

2.96

42.71

6.8

4.3

—

(3025941) Bacteria identified in Stool by Culture

310

1355

2.42

42.63

1.4

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1485

10921

1.66

42.51

4.6

2.8

191.50

131.98

ug/l

6.21

1393

10039

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

103

233

4.53

42.11

3.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

103

233

4.53

42.11

3.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

103

233

4.53

42.11

3.3

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

411

2036

2.17

42.00

5.9

4.1

0.08

0.11

0.72

213

666

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1149

7932

1.69

41.69

3.0

2.2

180.05

231.04

u/l

1.36

1111

7424

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

241

957

2.64

40.52

4.4

3.4

0.32

0.35

u/ml

0.50

141

544

(3000330) Specific gravity of Urine by Test strip

308

1373

2.37

40.47

6.2

3.5

—

(3033658) Prothrombin time (PT) actual/Normal

973

6491

1.71

39.67

7.3

4.0

86.21

87.31

0.64

948

6326

(3026493) Urate [Moles/volume] in Serum or Plasma

1011

6818

1.70

39.59

4.4

2.7

4682.81

6068.81

umol/l

0.50

912

5920

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

105

254

4.24

39.40

3.2

1.6

—

(3011412) CD3 cells [#/volume] in Blood

220

4.47

38.62

2.8

2.3

1.09

1.19

e9/l

0.45

199

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

858

5564

1.74

38.58

2.3

1.7

1.34

1.28

mg/l

0.21

688

4265

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

5.07

38.56

1.7

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

225

886

2.65

38.45

2.5

2.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

231

922

2.62

38.41

2.5

2.2

345.31

500.08

ug/l

0.74

215

867

(3037522) Nuclear Ab [Titer] in Serum

556

3170

1.91

38.21

1.5

1.3

506.06

512.52

titre

0.03

132

663

(3035350) Ketones [Presence] in Urine by Test strip

1631

12496

1.61

38.08

5.9

3.7

0.00

estimate

0.00

366

2527

(3021901) Oxygen saturation in Capillary blood

159

523

3.15

37.79

3.9

2.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

451

2402

2.02

37.78

3.1

2.2

0.20

0.21

g/l

0.39

414

2234

(3004588) Protein electrophoresis panel - Serum or Plasma

377

1879

2.14

37.74

2.7

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

132

5.56

37.54

4.0

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

5.56

37.54

4.0

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

164

553

3.07

37.36

3.0

2.8

36.65

36.64

umol/l

0.00

144

493

(3009261) Glucose [Presence] in Urine by Test strip

1638

12607

1.60

37.19

5.9

3.7

0.00

estimate

1.08

318

2285

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

356

1748

2.16

37.00

5.6

4.1

5.06

5.16

kpa

1.39

342

1649

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

5.31

36.71

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

142

5.31

36.71

1.8

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

184

669

2.86

36.63

5.0

4.0

2.11

1.59

mg/l

6.45

167

600

(3021601) Nitrite [Presence] in Urine by Test strip

1620

12466

1.60

36.58

8.3

5.0

0.00

estimate

0.40

328

2361

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

112

302

3.81

36.24

1.7

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

112

302

3.81

36.24

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

164

563

3.01

36.21

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

369

3.51

36.08

9.1

6.6

12.07

11.85

mg/l

0.21

118

342

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

281

3.90

35.94

5.1

3.3

62.44

56.27

1.70

236

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

100

251

4.08

35.74

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

101

256

4.04

35.62

2.4

2.5

—

(3009343) pH of Capillary blood

349

1725

2.15

35.61

5.7

4.1

7.41

0.07

201

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.37

35.49

3.5

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

575

3387

1.85

35.46

2.3

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

199

767

2.70

35.45

2.2

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

119

341

3.58

35.22

4.0

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

344

1699

2.15

35.15

2.1

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

422

2251

2.01

35.05

2.4

2.1

365.76

374.19

nmol/l

0.25

395

2045

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

242

4.10

34.95

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1118

7946

1.62

34.65

4.3

3.1

2518.75

1731.23

ng/l

4.07

998

6817

(3025159) Blasts/100 leukocytes in Blood

373

1913

2.07

34.50

5.7

4.1

0.32

0.42

0.11

170

544

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

336

1663

2.14

34.11

5.5

4.0

1.89

1.80

mmol/l

0.17

234

1212

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

489

2770

1.90

33.97

6.1

3.5

—

(3010421) pH of Blood

188

721

2.71

33.80

7.4

4.4

7.42

0.24

164

649

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

145

483

3.10

33.73

1.4

1.2

55.56

335.56

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

435

2382

1.95

33.42

4.1

3.0

286.41

232.70

ng/l

1.29

398

2167

(3021879) Hepatitis B virus core Ab [Presence] in Serum

340

1716

2.10

32.75

1.9

1.4

—

(3012501) Base excess in Blood by calculation

166

613

2.80

32.09

7.0

4.6

2.47

2.65

mmol/l

0.39

127

409

(3013290) Carbon dioxide [Partial pressure] in Blood

166

614

2.80

31.99

7.0

4.7

4.97

5.04

kpa

0.52

159

605

(3027315) Oxygen [Partial pressure] in Blood

166

614

2.80

31.99

7.0

4.7

8.06

8.47

kpa

2.54

159

604

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1354

10239

1.55

31.28

3.1

2.2

77.10

77.31

nmol/l

0.09

1246

9076

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

178

693

2.66

31.06

1.8

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

727

2.61

30.66

3.5

2.6

3.64

3.60

g/l

0.11

177

686

(3042733) HLA Ab [Presence] in Serum

6.85

29.71

5.1

4.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.99

29.48

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

704

4609

1.67

29.40

1.8

1.5

2.47

2.51

g/l

0.21

488

2797

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

203

865

2.44

29.34

3.6

3.3

53.03

72.34

mg/l

0.47

147

705

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

428

2428

1.88

29.33

4.0

2.4

6.99

7.20

ug/l

0.08

387

2104

(3003396) Base excess in Arterial blood by calculation

516

3110

1.78

29.01

9.6

7.1

0.85

1.09

mmol/l

0.58

406

2434

(3035947) Staphylolysin Ab [Units/volume] in Serum

122

5.08

28.92

1.3

1.1

3.20

5.20

iu/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1044

2.29

28.79

2.4

2.3

3.73

3.70

g/l

0.15

216

944

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1045

2.29

28.73

2.4

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1046

2.29

28.66

2.4

2.3

7.86

7.42

g/l

3.12

215

946

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

246

1153

2.23

28.51

3.8

1.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

197

839

2.44

28.50

3.6

3.3

1.93

1.73

ratio

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

139

498

2.87

28.43

4.9

3.6

59.17

58.23

0.29

139

498

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1525

11999

1.51

28.36

4.1

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

200

864

2.40

28.03

3.7

3.3

58.85

58.06

mg/l

0.03

147

701

(3019309) Folate [Moles/volume] in Red Blood Cells

775

5263

1.62

27.79

2.1

1.8

1190.58

1175.92

nmol/l

0.14

627

3963

(3016502) Oxygen saturation in Arterial blood

467

2785

1.79

27.09

10.2

7.5

95.33

95.40

0.09

444

2676

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1316

10115

1.51

26.94

6.2

3.8

45.43

54.67

ng/l

0.74

1009

7217

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

508

3110

1.75

26.91

9.7

7.1

4.99

5.10

kpa

1.64

486

2949

(3027801) Oxygen [Partial pressure] in Arterial blood

508

3110

1.75

26.91

9.7

7.1

11.28

12.04

kpa

3.58

486

2952

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

986

2.28

26.66

2.4

2.3

10.33

10.31

g/l

0.02

198

879

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

136

499

2.80

26.62

1.7

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

148

4.46

26.42

1.4

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

184

788

2.42

26.28

3.9

3.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

446

2651

1.79

26.10

4.4

4.0

22.57

21.53

ug/l

0.04

362

2188

(3016650) Hepatitis A virus Ab [Presence] in Serum

112

373

3.07

26.09

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

224

1049

2.22

25.99

2.9

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

168

4.17

25.73

3.4

2.1

558.13

709.18

e6/l

1.15

163

(3030905) Polymorphonuclear cells [#/volume] in Blood

131

481

2.80

25.61

4.1

3.4

4.32

4.34

e9/l

0.02

131

481

(40767503) Oxygen content in Capillary blood by calculation

146

569

2.64

25.43

4.0

2.5

15.75

16.02

0.30

289

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

375

2131

1.86

25.39

8.5

3.7

1.22

mmol/l

0.53

355

1838

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

114

390

2.99

25.35

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

153

612

2.57

25.28

2.4

1.9

12.65

11.73

mg/l

0.49

142

559

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

230

1104

2.17

25.09

5.7

5.2

1.74

1.63

0.35

217

1027

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

115

398

2.96

25.05

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

228

1094

2.17

24.89

5.7

5.2

0.86

0.88

0.48

215

1018

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

186

3.94

24.80

1.8

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

159

657

2.49

24.55

3.7

3.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.43

24.41

11.1

14.3

4.73

6.38

mmol/l

1.80

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

158

4.18

24.31

1.9

2.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.40

24.00

1.8

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

223

3.61

23.98

1.3

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

425

2552

1.77

23.91

10.7

7.9

117.09

121.37

g/l

3.87

413

2474

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

136

4.40

23.63

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

136

4.40

23.63

1.1

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

175

769

2.35

23.59

2.8

2.7

93.02

90.58

0.65

170

746

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

148

604

2.52

23.46

1.4

460.81

534.59

mg/l

1.98

139

569

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

198

923

2.22

23.22

3.2

3.1

261.52

4718.88

u/ml

0.85

163

783

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

102

4.96

23.21

5.0

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

102

4.96

23.21

5.0

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

121

449

2.76

23.20

1.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1141

8721

1.48

23.00

5.1

3.3

2.34

2.35

mmol/l

2.89

1048

7608

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.03

22.94

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

4.47

22.90

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

862

6227

1.52

22.88

1.8

1.6

18.88

20.10

nmol/l

1.49

775

5310

(3013707) Erythrocyte sedimentation rate by Westergren method

2161

18655

1.47

22.84

6.4

4.0

18.84

12.75

mm/h

37.40

2044

17205

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

104

4.87

22.70

5.1

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

117

432

2.77

22.65

2.9

2.0

1.52

1.71

mmol/l

1.80

117

423

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

4.20

22.63

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1362

10795

1.45

22.62

2.3

2.0

91.16

93.92

pmol/l

1.42

794

5682

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

135

537

2.58

22.57

1.5

11.44

28.42

e6/l

0.76

105

419

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

135

537

2.58

22.57

1.7

1.5

111.45

793.75

e6/l

1.87

110

439

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

865

6269

1.52

22.56

3.9

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

155

671

2.38

21.62

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

110

4.60

21.24

2.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

110

4.60

21.24

2.6

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

7.27

21.19

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

101

360

2.86

20.90

1.5

0.53

0.84

g/l

3.12

275

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

154

3.95

20.89

2.4

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.63

20.85

1.7

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

159

3.89

20.79

3.3

2.2

536.73

541.35

e6/l

0.02

136

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

151

3.96

20.63

2.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

975

2.11

20.57

2.6

2.3

3.31

2.98

g/l

3.67

184

875

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.84

20.55

1.1

—

(3024928) Oxygen saturation in Venous blood

132

545

2.48

20.44

6.9

2.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

131

539

2.49

20.43

1.3

3.92

3.81

mmol/l

0.43

122

500

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

160

722

2.28

20.29

1.6

1.5

0.43

9.21

iu/ml

0.55

148

(3024471) HLA-A [Type]

5.47

20.24

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

4.05

20.22

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

139

591

2.41

20.20

2.8

2.2

125.40

128.45

g/l

0.62

110

438

(3024932) HLA-DR beta [Type]

5.48

19.77

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

148

3.90

19.55

1.2

1.1

110.09

89.10

u/l

0.67

126

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

153

3.84

19.46

3.3

2.2

0.18

0.23

e9/l

1.14

135

(3036489) Thrombin time

188

930

2.08

18.95

2.6

2.2

22.10

21.55

0.55

173

830

(3044290) Cell count panel - Cerebral spinal fluid

119

486

2.50

18.87

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

182

892

2.10

18.80

2.9

2.4

0.45

1.15

g/l

2.38

159

770

(3041096) Erythrocytes [Presence] in Urine by Automated

890

6692

1.45

18.69

5.9

3.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

126

534

2.41

18.46

2.0

1.3

—

(3019060) Gas panel - Arterial blood

310

1831

1.77

18.28

6.3

4.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

254

1419

1.86

17.99

12.0

9.4

24.07

24.27

mmol/l

0.41

246

1369

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

105

414

2.59

17.93

1.6

1.3

—

(3004451) EKG impression Narrative

126

4.01

17.89

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

163

781

2.14

17.86

2.7

2.2

0.10

0.02

g/l

0.43

149

716

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.72

17.85

1.3

1.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

222

3.20

17.79

1.4

1.3

2.92

2.95

g/l

0.04

157

(3015171) Extractable nuclear Ab [Units/volume] in Serum

176

871

2.08

17.72

1.3

1.2

2.46

0.79

u/ml

0.54

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

195

1004

2.00

17.62

2.3

1.8

37.45

38.84

u/l

0.39

174

872

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.35

17.55

2.1

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

245

3.07

17.50

1.6

1.5

—

(4062490) Immunoglobulin typing, IgG

225

3.16

17.40

1.5

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

289

2.88

17.37

3.5

2.3

1.44

1.55

g/24h

0.11

150

(4035726) Immunohistochemistry procedure

345

2129

1.69

17.36

1.5

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

3.15

17.13

1.4

1.3

7.19

7.00

g/l

0.11

156

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

3.15

17.13

1.4

1.3

0.45

0.41

g/l

0.23

155

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.19

16.95

5.7

5.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1866

16099

1.37

16.91

4.8

3.1

69.92

50.52

u/l

8.49

1768

14916

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

114

4.08

16.84

1.4

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

110

458

2.45

16.77

2.0

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

4.26

16.67

1.1

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

221

3.12

16.61

1.8

1.1

—

(40768446) Kidney Pathology biopsy report

4.49

16.58

2.1

1.6

—

(3000012) Reticulocyte production index

100

401

2.54

16.51

3.6

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

134

614

2.23

16.42

1.8

1.6

20758.45

15189.18

e6/l

0.42

100

444

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

135

3.75

16.28

3.4

3.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

156

762

2.10

16.28

2.0

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1189

9589

1.38

16.23

6.6

3.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

219

3.10

16.22

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

285

2.82

16.06

3.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

309

2.73

15.91

2.3

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.84

15.89

4.2

2.3

—

(3021788) Differential panel - Synovial fluid

108

460

2.39

15.69

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

306

2.72

15.65

2.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

267

2.85

15.64

3.3

2.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

151

740

2.09

15.63

2.7

2.2

0.00

g/l

-0.00

139

678

(3023410) Appearance of Cerebral spinal fluid

246

2.93

15.55

1.6

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

736

2.09

15.47

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

129

597

2.21

15.45

2.0

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

781

5914

1.42

15.28

5.2

3.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

283

2.76

15.14

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

150

743

2.07

15.10

1.4

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

301

2.70

15.04

7.0

3.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

151

751

2.06

15.03

1.4

1.2

—

(3000494) Fungus identified in Specimen by Culture

429

2893

1.56

14.96

2.0

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

420

2820

1.56

14.93

2.7

2.2

190.42

143.29

ug/g

1.28

355

2223

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

244

1432

1.76

14.67

13.2

9.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

249

2.85

14.64

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

147

732

2.06

14.59

2.7

2.2

0.00

g/l

-0.00

139

677

(3045142) Bone marrow Pathology biopsy report

284

2.72

14.49

1.6

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

308

2.64

14.39

2.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

141

699

2.06

14.17

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

131

634

2.11

14.03

1.4

1.2

143.75

99.79

titre

0.23

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

217

2.94

13.97

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

145

3.42

13.96

2.7

38.69

40.80

0.23

(3008536) Aspergillus sp Ab [Presence] in Serum

5.13

13.62

4.5

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.66

13.52

1.4

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

330

2.52

13.50

4.9

2.6

—

(3023419) Bacteria identified in Sputum by Culture

399

2.37

13.34

2.6

2.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

156

820

1.95

13.32

2.7

2.1

34.84

37.56

g/l

4.94

140

720

(3047181) Lactate [Moles/volume] in Blood

161

857

1.92

13.25

5.7

6.0

1.35

1.32

mmol/l

0.15

135

744

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1723

14989

1.32

13.18

3.7

2.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

317

2051

1.60

13.16

4.9

2.7

54.57

64.10

ml/min/173m2

3.21

157

840

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

100

446

2.28

13.13

7.3

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

144

740

1.99

13.13

1.3

1.4

267.62

284.68

ug/g

0.45

436

(3022313) Gas panel - Capillary blood

216

1269

1.75

12.94

6.5

4.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

303

2.54

12.78

2.4

1.4

—

(40758292) HTLV I+II Ab panel - Serum

5.78

12.73

1.4

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

648

4884

1.41

12.72

4.2

3.0

2.47

2.45

mmol/l

3.06

577

4286

(3005988) Vibrio sp identified in Specimen by Organism specific culture

305

2.53

12.61

2.4

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

155

3.19

12.59

1.7

1.5

5.88

6.49

u/l

0.10

128

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

161

3.14

12.48

1.3

—

(3004775) Volume in Urine collected for unspecified duration

215

2.82

12.43

2.5

2.3

776.60

630.04

1.42

141

(3008152) Bicarbonate [Moles/volume] in Arterial blood

272

1722

1.63

12.33

9.6

6.7

24.06

24.52

mmol/l

1.21

255

1631

(3025468) Yersinia sp identified in Specimen by Organism specific culture

303

2.51

12.28

2.4

1.4

—

(3006270) Folate [Moles/volume] in Blood

239

2.71

12.27

1.2

335.41

365.63

nmol/l

0.46

199

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.06

12.10

1.3

1.6

—

(3044941) Cell count panel - Synovial fluid

407

2.27

11.90

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.42

11.90

1.6

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

188

2.90

11.80

1.2

129.09

titre

-0.00

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

136

718

1.93

11.50

2.5

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

314

2.42

11.41

1.5

1.4

27717.92

73580.79

e6/l

1.04

192

(3013512) EKG study

930

7540

1.33

11.29

6.0

4.0

—

(3042631) Mycobacterium sp identified in Specimen

354

2.32

11.20

2.9

2.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

386

2.26

11.18

1.7

1.5

31.22

31.62

g/l

0.10

353

(3000093) Morphology [Interpretation] in Blood Narrative

247

2.58

11.01

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

174

2.90

10.96

1.3

1.91

2.02

mmol/l

0.66

164

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

185

2.84

10.95

1.2

—

(3003181) Sodium [Moles/volume] in Urine

470

2.12

10.82

1.6

1.4

63.68

63.78

mmol/l

0.01

383

(3023199) Leukocytes [#/volume] in Pleural fluid

349

2.30

10.67

1.7

1.4

2716.32

1858.61

e6/l

0.32

253

(3009871) Measles virus Ab [Titer] in Serum

4.25

10.55

1.5

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2685

25197

1.38

10.55

39.3

15.1

32.01

25.03

mg/l

20.31

2467

20227

(40761535) Cells panel - Urine sediment

323

2206

1.52

10.52

5.7

3.4

—

(3012565) Volume of 24 hour Urine

116

3.30

10.39

2.7

1553.21

1951.56

1.05

102

(40761536) Microorganisms panel - Urine sediment

317

2162

1.52

10.39

7.1

4.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

117

611

1.95

10.25

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

198

2.70

10.21

1.9

1.4

15.29

13.74

u/l

0.62

187

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

331

2.30

10.17

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.50

10.16

5.6

4.7

5456.52

73.90

mg/l

0.48

(3016750) Collection duration of Urine

160

2.90

10.12

2.5

2.1

545.94

492.41

min

2.76

116

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

177

2.80

10.06

1.5

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

971

8025

1.30

10.02

4.9

3.8

21.64

11.57

mg/mmol

2.29

684

5163

(1001926) Buprenorphine [Presence] in Urine by Screen method

111

574

1.97

10.01

4.1

1.9

—

(3011288) Drugs identified in Urine by Screen method

100

500

2.03

9.92

7.5

3.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

3.50

9.88

4.2

3.9

50.53

52.92

0.24

(3012441) Differential panel - Pleural fluid

300

2.33

9.70

1.6

1.5

—

(3048879) Bone marrow aspiration report

3.74

9.59

3.1

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

605

1.92

9.55

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

128

3.07

9.50

4.1

3.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

291

2.33

9.45

1.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

324

2.25

9.36

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.36

9.32

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

244

1611

1.56

9.27

2.5

2.4

25.83

22.35

au/ml

0.16

111

(3036525) Urea [Moles/time] in 24 hour Urine

13.69

9.17

2.9

3.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

7.73

9.12

2.6

2.5

—

(3045788) Cell count panel - Pleural fluid

278

2.33

9.04

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

3.23

9.03

1.8

2.5

56.89

117.34

umol/l

1.72

(3004716) Salmonella sp identified in Stool by Organism specific culture

188

1181

1.63

8.82

1.4

1.3

—

(3011648) Oxygen content in Venous blood

202

2.55

8.80

3.6

2.6

10.67

11.17

0.32

202

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.13

8.71

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

121

676

1.82

8.67

4.2

2.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

349

2.15

8.61

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

379

2775

1.41

8.58

2.0

1.8

1.63

1.49

2.09

326

2421

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

145

2.78

8.22

1.2

—

(3022621) pH of Urine by Test strip

255

1747

1.50

8.18

3.5

3.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

272

2.27

8.15

1.9

2.0

—

(3028433) Virus identified in Specimen by Culture

3.58

8.12

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.77

8.06

1.4

1.1

—

(3037121) Protein [Mass/volume] in Urine

153

934

1.67

8.05

5.2

3.1

0.35

0.29

g/l

0.39

374

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.28

7.92

1.2

1.1

48.63

554.90

ng/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

349

2.09

7.84

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

116

2.95

7.80

7.3

6.5

36.57

55.53

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

486

1.90

7.56

1.2

1.00

4.74

u/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

262

2.24

7.54

1.4

1.3

329.49

336.55

u/l

0.04

252

(40757373) Influenza virus identified in Isolate

3.67

7.45

1.2

1.7

—

(3014271) Vancomycin [Susceptibility]

159

2.60

7.43

3.0

3.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

216

1460

1.51

7.41

1.4

1.3

58.17

54.49

au/ml

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.15

7.27

1.8

1.5

6.13

6.62

—

(3009508) Creatinine [Moles/volume] in Urine

944

8034

1.25

7.18

4.4

3.2

6.96

7.51

mmol/l

3.41

807

6756

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

643

5229

1.29

7.17

1.3

2.20

1.56

u/ml

0.42

149

1381

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.07

7.15

1.1

1539.83

1588.87

miu/ml

0.07

(3002256) Pathology report gross observation

428

3291

1.35

7.15

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

107

618

1.76

6.93

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

2.89

6.89

1.2

—

(40768441) Liver Pathology biopsy report

172

2.46

6.84

2.2

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.45

6.83

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.45

6.83

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

121

727

1.69

6.81

4.2

2.0

—

(3027008) Opiates [Presence] in Urine

122

735

1.69

6.80

4.2

2.0

—

(40768806) Pleura Pathology biopsy report

301

2.08

6.77

1.6

—

(3028300) Cannabinoids [Presence] in Urine

122

738

1.68

6.70

4.2

2.0

—

(3017704) Immunofixation for Urine

168

2.46

6.67

2.0

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

493

3906

1.31

6.67

1.7

1.5

—

(3027944) Amphetamines [Presence] in Urine

120

724

1.68

6.66

4.2

1.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.48

6.60

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.48

6.60

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.48

6.60

1.3

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.26

6.57

1.9

3.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

210

1448

1.48

6.56

1.6

1.3

352.41

238.16

u/ml

0.64

196

1336

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

145

922

1.60

6.55

1.1

66.32

1.67

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

353

1.98

6.55

1.2

1.62

3.89

u/ml

1.47

116

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.52

6.43

1.8

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.93

6.42

1.8

1.5

2.59

2.40

0.05

(3044007) Cell count panel - Peritoneal fluid

3.30

6.41

3.0

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

502

4013

1.30

6.34

1.3

33.44

35.67

iu/ml

0.15

159

1285

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

119

731

1.65

6.19

2.3

2.2

3923.74

4772.08

u/l

0.17

295

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.40

6.13

1.1

—

(3051651) Icteric interference index of Serum or Plasma

145

2.50

6.10

4.9

3.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

102

605

1.71

6.06

1.3

1.2

35.85

3.65

u/ml

0.63

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.60

6.05

1.0

1.1

—

(3020891) Body temperature

165

1102

1.52

6.03

8.3

4.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

103

614

1.70

6.01

1.3

1.2

3.21

9.35

u/ml

1.32

102

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

509

1.77

6.01

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.25

6.00

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

204

1425

1.46

5.99

3.3

4.25

4.45

pmol/l

2.19

176

1245

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

316

1.98

5.98

1.4

1.6

72.93

62.99

1.46

199

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

161

1072

1.53

5.98

7.2

4.5

24.36

24.80

mmol/l

1.12

152

986

(40768795) Lymph node Pathology biopsy report

222

2.18

5.97

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

654

1.67

5.95

1.3

1.2

17.20

39.48

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

178

2.32

5.92

2.0

1.4

112.63

85.42

umol/l

0.70

178

(3036782) Glucose [Moles/volume] in Pleural fluid

283

2.03

5.91

1.6

1.4

6.37

6.60

mmol/l

0.23

264

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.12

5.88

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

185

2.29

5.87

2.4

1.4

1.53

1.19

promille

0.68

140

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.01

5.79

1.1

—

(40768797) Stomach Pathology biopsy report

434

3447

1.30

5.74

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

2.92

5.72

3.0

1.8

—

(3012516) Albumin [Mass/volume] in Urine

883

7614

1.22

5.71

4.3

3.3

654.42

312.25

mg/l

1.15

624

4980

(3019832) Treponema pallidum Ab [Presence] in Serum

266

1970

1.38

5.64

1.9

1.6

—

(3019977) pH of Arterial blood

151

2.40

5.62

1.8

2.7

7.42

0.04

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

528

1.72

5.59

3.1

2.0

0.96

0.82

nmol/l

0.83

435

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.03

5.53

5.0

3.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

243

2.07

5.51

1.7

1.4

23.81

26.64

0.23

145

(3039162) Centromere protein B Ab [Units/volume] in Serum

284

1.99

5.50

1.3

1.2

39.94

54.23

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

312

1.94

5.49

9.3

7.6

7.66

7.67

mmol/l

0.01

265

(3020393) Adenovirus Ag [Presence] in Stool

4.61

5.47

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

677

5706

1.24

5.42

1.9

1.7

10052418.91

27911347.91

pmol/l

0.85

577

4715

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.19

5.38

1.5

2.5

—

(3035880) pH of Pleural fluid

167

2.29

5.37

1.7

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.69

5.25

1.0

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

2.28

5.21

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

126

2.47

5.20

1.2

1.1

72.61

87.34

u/l

0.80

116

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

106

664

1.62

5.17

2.7

2.2

195.44

99.45

ug/min

1.00

414

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.73

5.10

3.5

2.4

417.16

800.83

e6/l

1.18

(3022145) Colonoscopy Study observation

345

2700

1.31

5.09

1.5

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.85

5.08

3.3

2.2

8268.00

23963.25

e6/l

0.35

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

165

2.26

5.07

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

644

1.62

5.06

1.3

204.16

222.69

miu/ml

0.19

281

(3033799) Differential panel - Peritoneal fluid

2.91

5.03

2.9

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

344

1.85

5.01

1.3

1.2

2.69

5.28

u/ml

1.46

151

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

235

3127

0.73

5.01

4.6

4.5

31.75

32.63

0.61

185

2110

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

2.42

4.96

1.6

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.02

4.91

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

470

3844

1.26

4.90

1.3

1.2

10.35

12.54

u/ml

0.29

169

1481

(3003338) MCHC [Mass/volume]

2227

21023

1.19

4.88

42.2

19.4

330.43

332.21

g/l

15.12

2203

20818

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.17

4.76

13.8

8.1

—

(3050794) Legionella sp Ab [Presence] in Serum

5.73

4.75

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

132

1922

0.67

4.74

1.6

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.85

4.65

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

136

1960

0.68

4.64

1.4

1.3

—

(21494434) Karyotype in Bone marrow

253

1.95

4.63

1.1

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

5.47

4.60

1.2

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

475

1.68

4.56

1.3

1.2

51.42

40.79

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

108

703

1.55

4.52

3.2

2.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.02

4.52

1.3

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

201

2.05

4.48

1.5

1.3

23.15

13.83

u/l

0.81

188

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

215

2.01

4.46

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

293

1.86

4.42

1.3

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

466

1.67

4.35

1.2

129.72

40.63

u/l

1.70

398

(3016038) Potassium [Moles/volume] in Urine

170

2.13

4.34

1.6

1.2

35.25

mmol/l

0.00

153

(3034274) Bile acid [Moles/volume] in Serum --fasting

260

1.90

4.30

2.4

2.1

8.21

8.13

umol/l

0.01

182

(3019150) Specific gravity of Urine by Refractometry

643

5510

1.21

4.29

6.2

4.2

1.02

kg/l

0.40

111

815

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.27

4.29

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.27

4.29

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

241

1838

1.34

4.29

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.91

4.28

1.9

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

1.92

4.25

1.6

1.3

183728.97

110833.71

e6/l

0.18

168

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

233

1.94

4.25

2.2

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

547

1.61

4.24

4.4

3.3

91.96

900.87

u/ml

1.05

505

(40759836) Histone Ab [Presence] in Serum by Immunoblot

173

2.09

4.16

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.09

4.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.09

4.16

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1292

0.63

4.14

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

152

1082

1.42

4.13

3.9

3.2

77.98

55.83

u/ml

0.30

147

1044

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.80

4.12

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.87

4.06

1.2

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

2.87

4.06

1.6

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

618

1.55

4.03

3.5

3.1

0.87

0.82

nmol/l

0.48

473

(3013862) HLA-DP [Type]

10.02

4.01

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.06

4.00

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.06

4.00

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.06

4.00

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.90

3.99

1.1

92.64

96.11

0.18

(3023511) Choriogonadotropin [Units/volume] in Urine

378

1.71

3.99

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

185

1372

1.37

3.97

2.6

2.4

—

(3002619) Bacteria identified in Specimen by Culture

3.13

3.92

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2387

24850

0.85

3.89

5.2

4.9

2.57

2.68

mmol/l

7.18

2219

22752

(3011985) Renin [Units/volume] in Plasma

299

1.79

3.87

1.4

59.46

62.96

mu/l

0.08

259

(3024263) Appearance of Synovial fluid

145

2.15

3.86

1.5

1.4

—

(3045414) Leukocytes [Presence] in Urine

161

1173

1.39

3.85

2.8

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

354

1.71

3.77

1.1

—

10.61

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.60

3.74

2.6

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

467

5509

0.82

3.73

2.8

3.1

0.79

0.80

ug/l

0.09

335

3717

(3036071) Salmonella sp Ab [Titer] in Serum

2.57

3.71

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.15

3.70

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

151

1099

1.39

3.65

2.4

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

2247

21424

1.16

3.63

39.4

17.7

15.05

15.19

0.27

2214

21009

(3023383) Lactate [Moles/volume] in Pleural fluid

2.43

3.63

1.5

1.3

3.54

3.36

mmol/l

0.08

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.72

3.59

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.95

3.57

1.7

1.3

—

(3007463) Buprenorphine [Presence] in Urine

7.79

3.56

3.7

3.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.77

3.55

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2678

25912

1.19

3.51

39.7

17.5

139.12

139.60

mmol/l

16.23

2615

25223

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

10.02

3.49

1.0

0.24

0.19

g/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.37

3.48

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

340

1.69

3.47

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

223

1.85

3.41

1.1

1.0

—

(40768804) Tissue Pathology biopsy report

1103

10049

1.15

3.37

2.4

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.84

3.35

1.3

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2681

25974

1.18

3.31

40.2

17.7

3.99

3.98

mmol/l

0.18

2615

25243

(3051611) Lipemic interference index of Serum or Plasma

262

1.77

3.31

4.4

3.3

—

(46236302) HLA-C [Type] by High resolution typing

8.58

3.26

1.0

—

(40760409) HLA-A [Type] by High resolution

8.58

3.26

1.0

—

(40760410) HLA-B [Type] by High resolution

8.58

3.26

1.0

—

(40763590) HLA-DQ beta [Type]

8.58

3.26

1.0

—

(4281824) Cell count and differential, peritoneal fluid

234

1.81

3.25

1.5

1.2

—

(3042517) Benzodiazepines panel - Urine

4.75

3.23

1.1

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.34

3.22

1.6

1.1

0.70

1.21

mmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

402

1.60

3.22

1.8

4.30

4.94

mmol/24h

0.71

345

(3044889) 12 lead EKG panel

1864

17614

1.14

3.22

5.0

3.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.18

3.19

1.2

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.87

3.19

16.8

8.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

144

2.02

3.15

1.8

1.4

1.21

1.18

nmol/l

0.04

111

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

111

2.17

3.12

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.01

3.08

1.2

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

315

1.66

3.03

1.7

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1985

18876

1.13

2.99

4.4

3.9

14.68

14.85

pmol/l

2.11

1837

17050

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

10.01

2.98

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

141

1.99

2.95

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

141

1.99

2.95

1.6

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

191

1.84

2.92

1.3

1.5

23.71

22.80

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.45

2.89

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.45

2.89

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2329

24139

0.88

2.89

5.3

4.6

6.16

5.99

mmol/l

5.52

2136

21816

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2327

24118

0.88

2.88

4.9

4.4

1.36

1.44

mmol/l

16.24

2168

22065

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

185

1.85

2.87

2.8

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2348

24318

0.88

2.86

4.9

4.4

4.40

4.56

mmol/l

10.54

2190

22408

(40768443) Skin Pathology biopsy report

144

1086

1.34

2.86

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.17

2.85

2.4

1.7

208.53

147.95

ng/l

0.31

(3035320) C reactive protein [Mass/volume] in Body fluid

179

1.85

2.82

3.6

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

687

7676

0.87

2.81

3.8

4.4

23.46

21.93

1.60

350

3798

(3039000) Anion gap in Blood

596

1.45

2.80

8.2

7.0

11.79

11.22

mmol/l

0.81

526

(3018572) Chloride [Moles/volume] in Blood

597

1.45

2.78

8.2

7.0

104.51

105.27

mmol/l

0.73

527

(3008295) Osmolality of Serum or Plasma

277

1.67

2.77

1.2

1.4

278.68

279.57

mosm/kgh2o

0.07

203

(3016135) IgD [Mass/volume] in Serum

8.34

2.75

1.4

1.3

41.50

131.88

mg/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.01

2.72

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.24

2.72

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.72

2.71

1.5

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.60

2.70

1.6

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

2.51

2.70

2.3

2.1

158.89

251.00

e6/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.29

2.67

3.1

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

243

1.70

2.63

2.3

2.0

1.62

1.90

u/field

0.14

(3036670) Protein [Mass/volume] in Synovial fluid

2.26

2.60

1.1

1.2

33.16

39.10

g/l

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

20.16

21.12

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

38.10

37.04

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

7.33

7.98

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.30

2.57

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.36

2.55

1.3

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

2.8

3.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

2.8

3.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.15

2.55

1.0

1.3

—

(3013762) Body weight Measured

5.46

2.54

1.0

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

308

1.60

2.52

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.47

2.48

4.4

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

287

1.61

2.45

1.3

—

nmol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

233

1.68

2.45

1.2

1.3

1.67

1.44

nmol/l

0.47

207

(3034891) Synovial lining cells/100 cells in Synovial fluid

123

1.96

2.45

1.5

1.4

5.67

4.79

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

563

1.43

2.45

2.0

1.9

3.54

4.55

iu/l

0.67

191

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

189

1.75

2.41

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

336

1.56

2.40

1.3

0.12

0.35

nmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.01

2.40

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

2.40

29.2

10.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.42

2.36

1.9

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.12

2.36

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.04

2.35

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

160

1265

1.28

2.31

1.9

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

133

1.89

2.31

14.0

13.6

892.84

828.30

nmol/l

0.30

127

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

105

2.01

2.30

2.1

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.23

2.27

1.6

1.3

6.84

98.35

ug/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.56

2.27

3.0

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.07

2.27

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

186

1502

1.25

2.26

1.3

1.2

124.85

140.13

iu/ml

0.21

553

(3009677) Dengue virus Ab [Presence] in Serum

5.56

2.21

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

2.21

4.4

5.0

339.00

409.56

umol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

749

6817

1.13

2.20

6.8

4.1

0.00

estimate

1.28

293

2253

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.07

2.16

1.1

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

2.16

2.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

2.16

2.0

2.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.29

2.15

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.14

2.08

1.6

69.34

171.44

nmol/24h

0.62

(3025018) Bordetella pertussis Ab [Titer] in Serum

131

1.84

2.07

1.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.91

2.07

2.7

1.2

—

640.53

—

(3006653) Thiamine [Moles/volume] in Blood

124

1.86

2.06

1.1

1.2

134.43

139.22

nmol/l

0.16

124

(3025549) Creatine [Moles/time] in 24 hour Urine

3.51

2.05

1.1

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.51

2.05

1.1

—

(3003694) ABO and Rh group [Type] in Blood

745

6812

1.12

2.02

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.82

2.00

1.3

1.0

—

(3047189) Immunofixation for 24 hour Urine

133

1.81

1.99

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

120

935

1.29

1.99

1.5

1.4

24.65

26.31

iu/l

0.24

109

789

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

149

1.75

1.94

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.75

1.93

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.73

1.93

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

282

1.53

1.92

1.3

27.01

24.80

u/l

0.15

229

(3025130) Human papilloma virus identified in Specimen

266

1.55

1.92

2.3

1.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

180

1.67

1.91

1.2

1.1

—

3.70

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

389

1.45

1.90

1.1

10.38

1578.52

iu/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

241

2043

1.19

1.87

1.5

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

166

1.69

1.87

2.8

1.5

0.91

0.95

g/l

0.40

166

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

1.86

1.4

1.2

—

(3034426) Prothrombin time (PT)

2.09

1.86

1.1

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.53

1.83

1.3

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2264

23300

0.91

1.82

4.5

3.9

1.41

1.29

mmol/l

8.74

2100

21158

(3017569) Oxygen content in Arterial blood

130

1.77

1.81

1.4

2.5

—

(3029075) Extractable nuclear Ab panel - Serum

2.06

1.80

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

199

1.61

1.80

1.2

1.1

—

66.62

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.00

1.79

3.8

1.7

2.16

1.97

umol/l

0.39

(3017732) Neutrophils [#/volume] in Blood

202

1695

1.20

1.77

3.5

3.2

5.28

5.45

e9/l

0.07

161

1355

(3009214) Lutropin [Units/volume] in Serum or Plasma

627

1.33

1.75

1.3

1.4

10.87

9.20

u/l

0.54

505

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.74

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

339

1.45

1.72

1.2

1.1

1.69

1.53

g/l

1.60

309

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.67

1.72

1.4

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

1.72

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.14

1.71

2.1

3.5

—

102.41

au/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

148

1.69

1.70

1.0

1.1

12.25

12.32

iu/ml

—

(40765096) Chromosome analysis panel by Banding

1.91

1.69

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

633

0.69

1.67

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

122

980

1.25

1.63

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.58

1.61

1.0

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

447

1.37

1.58

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

130

1.70

1.52

12.5

13.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.34

1.52

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

241

1.50

1.52

1.6

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.60

1.51

10.6

4.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.83

1.51

1.2

1.3

141.71

167.80

mmol/24h

0.73

(40768800) Prostate Pathology biopsy report

595

0.70

1.49

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

342

1.41

1.48

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.23

1.46

1.4

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

117

1.71

1.44

2.1

46.74

50.63

umol/l

0.20

(3017315) Amylase [Enzymatic activity/volume] in Urine

125

1.68

1.43

1.2

221.86

352.26

u/l

0.55

112

(3024869) Neuronal Ab [Presence] in Serum

2.31

1.43

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

288

3257

0.87

1.42

15.4

7.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.42

1.39

1.0

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.42

1.39

1.4

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

135

1.63

1.35

2.6

2.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

442

0.68

1.34

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

1.97

1.32

1.2

1.3

118.58

69.99

mu/l

0.30

(3039443) Prostate specific Ag panel - Serum or Plasma

464

0.69

1.32

1.6

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

392

0.66

1.31

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.50

1.30

1.0

1.4

1.94

0.84

ml/s/173m2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(3019225) pH of Specimen

296

2634

1.14

1.30

9.9

4.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.78

1.28

8.4

5.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.29

1.26

1.6

1.2

226.53

122.20

ng/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

1.24

1.1

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

253

1.43

1.24

1.1

104.03

95.21

0.93

240

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

131

1.61

1.23

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

324

0.65

1.20

1.1

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.31

1.18

1.3

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

133

1.58

1.17

1.1

1.04

1.16

u/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

134

1.57

1.14

1.7

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

175

1.49

1.12

1.6

1.3

3.40

1.46

u/ml

0.53

101

(3021387) Prolactin [Units/volume] in Serum or Plasma

781

1.22

1.11

1.7

1.6

362.20

305.40

mu/l

0.62

704

(3013293) Extractable nuclear Ab [Presence] in Serum

2.26

1.10

1.1

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.93

1.06

1.7

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.27

1.03

1.6

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

114

1.58

1.02

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

163

1.48

1.01

1.1

4.52

3.91

nmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.88

1.00

1.7

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.88

1.00

1.0

1.1

—

5.80

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

1.00

2.1

1.4

43.86

46.09

umol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

138

1189

1.17

1.00

1.1

1.0

—

(4200892) Spirometry reversibility

199

1764

1.14

0.98

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

166

1.45

0.94

1.0

808.16

680.82

ng/l

0.52

101

(3004616) Nuclear Ab [Presence] in Serum

294

1.33

0.94

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2387

23446

1.07

0.93

31.2

14.1

75.90

78.92

ml/min/173m2

6.59

2151

19384

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

232

2093

1.12

0.88

2.1

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

869

0.82

0.87

2.1

1.6

10.69

3.76

mg/l

1.28

633

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.00

0.87

8.2

8.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

1.43

0.86

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.82

0.85

2.3

3.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.82

0.85

1.3

2.3

15.13

17.98

umol/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.82

0.85

4.5

6.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

255

2318

1.11

0.85

2.1

2.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.94

0.84

3.7

2.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.57

0.84

4.4

2.8

29.20

29.23

umol/l

—

(3020491) Glucose [Moles/volume] in Blood

197

1.37

0.82

1.5

2.0

7.34

6.97

mmol/l

0.16

132

(4034850) Laboratory test

839

0.83

0.81

15.4

10.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

311

1.29

0.81

1.3

1.5

0.21

0.34

nmol/l

1.93

254

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

320

1.28

0.80

1.1

1.65

2.52

u/ml

0.65

133

(3038177) Helicobacter pylori Ab [Presence] in Serum

356

1.27

0.80

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2325

22862

1.06

0.79

5.3

4.7

3.13

2.05

mu/l

0.45

2183

20807

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

303

3286

0.91

0.79

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

260

1.31

0.78

1.3

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

1.44

0.76

1.0

1.1

1.04

1.05

ratio

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

459

1.22

0.74

1.6

1.5

319.81

196.29

pmol/l

0.31

452

(3001019) Free T4 and TSH panel - Serum or Plasma

1098

0.86

0.73

1.9

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.84

0.73

1.3

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.72

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.85

0.68

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

896

0.86

0.67

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.63

0.66

2.4

3.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.61

0.65

1.8

—

(40768793) Breast Pathology biopsy report

486

1.20

0.64

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

241

2610

0.92

0.64

1.6

—

(1761868) Lipid panel - Serum or Plasma

792

8237

0.95

0.64

3.4

2.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

926

9590

0.95

0.63

4.7

5.1

4.05

3.61

ug/l

0.20

826

8532

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.67

0.61

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.03

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

122

1.40

0.60

3.4

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

649

0.84

0.58

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

11.17

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

1.42

0.57

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

150

1.34

0.55

1.3

2.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

116

1.38

0.54

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

125

1.36

0.53

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2755

27777

0.95

0.53

49.8

22.0

7.29

6.85

e9/l

8.26

2694

26925

(3015183) Erythrocyte sedimentation rate

117

1.37

0.52

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

434

1.18

0.51

2.3

1.5

—

(3008898) HLA-B27 [Presence]

762

1.13

0.51

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.49

0.49

2.2

1.3

23.00

22.67

—

(3026361) Erythrocytes [#/volume] in Blood

2756

27774

0.95

0.49

49.7

22.0

4.28

4.46

e12/l

49.92

2690

26925

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

642

1.14

0.49

1.2

1.1

7.03

6.05

u/ml

0.09

(3000963) Hemoglobin [Mass/volume] in Blood

2757

27782

0.95

0.49

50.1

22.1

127.85

134.53

g/l

81.19

2715

27314

(3035941) MCH [Entitic mass]

2756

27772

0.95

0.48

49.5

21.9

30.17

30.34

5.19

2714

27299

(3024731) MCV [Entitic volume]

2756

27771

0.95

0.48

49.6

21.9

91.24

91.19

0.23

2715

27302

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

871

1.12

0.47

1.8

1.6

—

(3007461) Platelets [#/volume] in Blood

2755

27758

0.95

0.47

49.8

22.0

247.13

246.88

e9/l

0.06

2693

27000

(3009542) Hematocrit [Volume Fraction] of Blood

2755

27749

0.95

0.44

50.5

22.1

37.97

39.85

34.39

2574

25852

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

239

1.22

0.42

2.0

1.5

2.17

3.34

ug/l

0.89

212

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.64

0.42

1.2

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.00

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2673

26530

1.04

0.40

20.3

10.3

27.06

26.04

u/l

0.45

2615

25508

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.06

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.39

0.38

1.8

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.35

0.38

4.0

2.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.35

0.37

1.8

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

300

1.17

0.36

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

245

0.82

0.36

1.1

1.0

0.30

0.26

u/ml

—

(3000285) Sodium [Moles/volume] in Blood

1.40

0.35

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

583

0.89

0.33

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

391

0.87

0.32

1.6

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

399

1.13

0.31

1.8

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.73

0.30

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

147

1.23

0.30

2.3

1.6

3.38

2.32

u/field

0.19

108

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.27

0.30

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

109

0.73

0.29

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

805

1.08

0.28

1.6

1.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.32

0.28

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

521

0.90

0.27

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

169

1.18

0.25

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.18

0.24

1.1

1.3

7.72

9.00

ug/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

474

0.91

0.23

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.25

0.22

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

399

0.90

0.22

1.6

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

13.14

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.60

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.89

—

(3005033) Fetal Nuchal fold Thickness US

388

0.90

0.21

1.5

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2280

22939

0.98

0.20

7.4

5.9

41.71

40.22

mmol/mol

8.22

2125

21094

(40761511) CBC panel - Blood by Automated count

2589

26012

0.98

0.20

31.2

14.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.22

0.20

2.7

6.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

1.15

0.18

1.5

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

477

0.92

0.18

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

279

0.90

0.17

1.1

2.25

3.43

u/ml

0.53

135

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

476

0.92

0.17

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

475

0.93

0.17

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

148

1.15

0.17

2.4

2.0

278.00

131.92

ug/min

—

(3032773) Endomysium IgG Ab [Titer] in Serum

196

1.12

0.16

1.1

—

(3006462) Nitrate [Presence] in Urine

118

0.85

0.14

2.1

3.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

139

0.86

0.14

1.1

1.4

1.32

1.55

g/l

3.45

139

(4146454) Self-monitoring of blood glucose

284

0.91

0.13

2.9

2.5

—

(1002224) Polysomnography panel

902

1.04

0.13

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

116

0.86

0.12

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

627

6344

0.99

0.11

1.8

1.6

1.49

1.36

mmol/l

2.82

548

5320

(3000034) Microalbumin [Mass/volume] in Urine

230

1.09

0.11

3.1

231.61

29.14

mg/l

0.73

177

(44813793) Dust mix specific IgE antibody measurement

145

1.10

0.09

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.07

0.08

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

113

0.88

0.08

1.0

1.1

0.60

22.45

u/ml

—

(3013637) Mi-2 Ab [Presence] in Serum

0.79

0.08

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.79

0.08

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.79

0.08

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.79

0.08

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.14

0.08

3.2

2.0

15.19

109.71

ug/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

677

1.03

0.08

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

1.04

0.08

1.1

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

161

1579

1.02

0.07

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.83

0.07

1.3

1.4

32.51

34.76

nmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

356

0.95

0.06

1.0

1.1

1.03

1.38

u/ml

0.23

156

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

207

1.06

0.06

1.1

—

(3000492) Spirometry study

234

2311

1.01

0.06

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

230

1.04

0.03

1.5

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

171

1.05

0.03

1.4

165.90

160.31

pmol/l

0.08

171

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

410

0.98

0.02

1.0

1.1

1.93

2.47

u/ml

0.19

217

(3023430) Cat dander IgE Ab [Units/volume] in Serum

253

1.03

0.01

1.1

4.12

5.06

u/ml

0.16

104

(3051387) C reactive protein [Mass/volume] in Capillary blood

613

1.01

0.01

6.6

3.6

33.33

27.94

mg/l

0.62

399

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

126

0.95

0.00

1.2

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

115

0.96

0.00

1.1

1.2

0.47

3.52

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

125

1.04

0.00

1.1

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

136

1.03

0.00

4.4

3.5

32.19

30.76

mu/l

0.04

131

(3003888) Timothy IgE Ab [Units/volume] in Serum

366

1.01

0.00

1.0

1.1

7.68

5.36

u/ml

0.34

190

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

308

1.01

0.00

1.3

7.38

7.44

mmol/l

0.03

268

(3010726) Horse dander IgE Ab [Units/volume] in Serum

342

0.99

0.00

1.1

1.06

1.44

u/ml

0.32

181

(3017446) Testosterone [Moles/volume] in Serum or Plasma

191

1912

1.00

0.00

2.4

2.2

12.02

12.44

nmol/l

0.28

165

1690

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

137

1.02

0.00

4.2

6.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.00

-0.00

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.00

-0.00

1.8

1.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.01

-0.00

2.1

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.89

-0.00

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.43

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

9.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_INFECTIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	2.899 [2.57, 3.27]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.203

During the follow-up period (1.1.1998 — 31.12.2019), 5152 out of 11728 females with AB1_OTHER_INFECTIONS died.

Males

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	3.052 [2.66, 3.49]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5986 out of 12760 males with AB1_OTHER_INFECTIONS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_INFECTIONS.

N-year risk	Females	Males
1	0.244%	0.699%
5	1.528%	3.358%
10	4.186%	7.93%
15	8.183%	15.529%
20	14.109%	25.974%

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_INFECTIONS – Other infectious diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infectious diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints